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ABSTRACT
Matrix assisted laser desorption/ionisation mass spectrometry imaging is a recent 
addition to the existing family of molecular imaging technologies. It has the capacity to 
map the distribution of molecules within a biological tissue section, without the need for 
radionuclide or fluorescent labelling procedures.
The primary aim of the work presented in this thesis was to assess the use of a high 
repetition rate laser for MALDI-MS image analysis by developing methodologies for 
the detection of a number of different compounds from a variety of biological tissues. 
Additional investigations include and examination of strategies for normalisation and 
statistical interpretation of MALDI-MS image data.
The application of a solvent assisted indirect imaging approach for the analysis of drugs 
in skin is described. Studies have been carried out in order to gauge how the use of a 
solvent in the blotting process aids the indirect imaging technique. Further experiments 
have been performed to assess the level of analyte migration induced by incorporation 
of a sample wetting step.
In a direct tissue imaging experiment the distribution of a prodrug and its active 
metabolite has been determined in treated tumour tissue. Endogenous markers have 
been employed to assist in determining correlation between drug activation and hypoxic 
regions within tumours.
Different methods of data normalisation are investigated for their effects on image data, 
and statistical evaluation of MALDI-MS acquired image data have been examined in 
relation to extracting hidden variables from multidimensional image data sets.
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1.0 Introduction
Living organisms as a whole are the most complex structures in the known universe and 
their intrinsic mechanisms and interactions have always fascinated man. Over the past 
few centuries, man’s understanding of the complexities of biological systems has 
increased substantially. One of the most powerful tools used to gain this knowledge has 
been the generation of images.
The study of living organisms has historically relied on the view and illustration of 
biological systems. From Vesalius’ early studies of human anatomy1 to molecular 
structure elucidations at the atomic level, the most practical sense of acquiring and 
relaying information has been through visualisation and representation as an image. As 
a result, many techniques have been developed to allow researchers to look at organisms 
in different ways.
During the 20 century, biological examinations were directed toward the determination 
of tissue and cellular anatomy. This was promoted through the advent of electron 
microscopy in the early 1930’s.2 Later with the discovery of the DNA double helix, a 
new generation of research was bom. The mapping of the genome transformed the way 
that living organisms are considered.
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With greater depth in understanding of the underlying complexity of biological systems, 
researchers have begun to look at living organisms from a very different perspective. 
Where the traditional methods of biological study determine the gross structure and 
organisation of tissues and cellular components, the latest innovations in biomedical 
imaging are directed toward examining the distribution of the molecules within. The 
ability to see biochemical or biological events as they occur in situ has been pivotal to 
many areas of scientific research.
1.1 Biochemical Imaging Sciences
Insight into biochemical systems from the anatomic to the subcellular level is now the 
basis of developmental, pathological, and pharmaceutical research. Both in medicine 
and research images are often generated to determine biochemical processes, either by 
tracking the path or by mapping the distribution of certain natural or synthetic chemical 
entities.
Molecular imaging is a broad title given to a number of techniques that are concerned 
with the production of images of molecular distribution in tissues and cells. Here the 
principles and applications of the basic biomedical imaging technologies are examined.
3
1.2 Imaging Techniques
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Images are an effective means o f storing and displaying high volumes of information. 
Molecular images are created through recording the detection of signals from defined 
points within a sample. The signal responses are stored along with their co-ordinate of 
spatial origin within the sample. These data can then be processed and represented in 
the form of a digital image. In an image, the intensity of the signal response for each 
specific pixel is defined by a change in brightness, or alternatively by a change in colour 
or hue.
The amount of data collected for each pixel is defined by the number of different signal 
responses measured in the analysis. This is broadly governed by the type of imaging 
technique employed. Imaging techniques can also provide three dimensional image 
data. This is achieved by acquiring signals from a series of sequential two dimensional 
slices and digitally joining the slices of data together to form a volumetric image set.
The imaging systems available vary in invasiveness. They also differ in resolution, 
penetration depth, acquisition time, sensitivity and specificity. Clearly, the invasiveness 
of the imaging technique largely defines its application. Some techniques are relatively 
harmless and can be carried out on living subjects with little preparation or serious side- 
effects. These techniques tend to be applied in medicine as diagnostic technologies.
4
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Some techniques require labeling procedures or administration of contrast agents to 
promote signal responses. Others require procedures which are harmful or cause 
destruction of the organism under examination. These techniques tend to be reserved 
primarily for laboratory research purposes.
Whilst many imaging modalities tend to focus on acquisition of one or a few different 
signal responses, some carry the potential to detect a broad spectrum of signals 
simultaneously. With the rate at which scientific knowledge is growing, these 
techniques are becoming increasingly popular in research.
The non-invasive molecular imaging modalities that may be carried out on living cells 
or tissues include nuclear magnetic resonance imaging, some forms o f optical imaging, 
single photon emission computed tomography and positron emission tomography.
Invasive imaging technologies involving harm or destruction to samples include some 
forms of optical imaging, autoradiography and most forms of mass spectrometry 
imaging.
1.2.1 Nuclear M agnetic Resonance Imaging
Nuclear magnetic resonance imaging (NMRI), commonly referred to as magnetic 
resonance imaging (MRI), is a non-ionising radiation technique. It is widely regarded 
as one of the most powerful non-invasive imaging technologies available in clinical 
diagnostics and biomedical research.
5
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MRI has the ability to distinguish between two fundamentally similar, but not identical 
tissue types. The technique is routinely used by clinicians to evaluate demylinating 
disorders and for the detection of pathological tissues such as tumours. Additional 
related approaches include functional MRI and magnetic resonance angiography. These 
are used for the assessment of neural activity and stenosis respectively. MRI is further 
applied in medical interventions such as radio and ultrasound therapy to provide 
navigational guidance for the therapist during the course of treatment.
In MRI, absorption and emission of energy in the radiofrequency range o f the 
electromagnetic spectrum creates detailed tomographic or volumetric images. The 
technique is based on the principle o f spin properties of various atoms when subject to 
electromagnetic forces.
Images are generated from nuclear magnetic resonance signals and are usually obtained 
using the spin property of the hydrogen atoms in the tissue. As hydrogen content varies 
between tissues, adaptation of pulse sequences can produce contrasting signals between 
various tissues types. As a magnetic field is applied, hydrogen protons become almost 
equally aligned (Bo) or counter aligned with the magnetic field. Bo alignment is slightly 
favoured as the nucleus is at lower energy in this position. As a result there is a net 
magnetisation pointing in the direction of the Bo field. Bi RF pulses are applied to force 
the protons to spin away from B0 at an angle of 90° (figure 1.1).
6
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The direction of net magnetization is, over time, altered to align with the Bi field. It is 
in this conformation that the radio frequency signal can be detected. As the RF pulse is 
removed, the protons return to their original B0 alignment. This is known as relaxation. 
The energy released as the protons return to the original state acts as a response signal. 
The signals detected are converted through Fourier transform to produce images.
Figure 1.1 The principle of MRI
In a strong magnetic field (Bo) the hydrogen nuclei precess about the direction of the 
field (a). The radio frequency pulse realigns the magnetic moment to the Bi direction. 
During relaxation, once the RF pulse is removed, the hydrogen nuclei return to Bo. The 
loss in nuclear energy as the protons return to the original state, produces a measurable 
RF signal that can be used to produce an image.
(a) (b)
Bo Bi
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Resolutions of approximately 1mm are routine in clinical diagnostics. This is in 
accordance with the requirements of current medical applications. With the latest 
adaptation of MRI which incorporates some attributes of atomic force microscopy, 
image voxel sizes in the region of 1pm are possible. Using this technique, known as 
magnetic resonance force microscopy (MRFM), images may be produced where a 
single cell contains approximately 1,000,000 image voxels.3,4 The most recent reports 
of high resolution MRFM boast resolutions of 20nm.5
High resolution MRI is used in research as a non-invasive approach for in vivo studies. 
High spatial resolution and high anatomical contrast combined with the ability to label 
cells with MR contrast agents allows mapping of microscopic events such as cellular 
migration. This method has been influential in assessing the pathogenecy of a number 
of diseases. 6
1.2.2 Optical Imaging
Optical imaging is the name given to a number of non-ionising imaging techniques. 
They are based on various physical parameters of light interaction with tissues or 
molecules. These techniques can be used to determine structural properties as well as 
chemical and functional changes within tissues. There are a number of optical in vivo 
and in vitro imaging systems that are currently used in research. Each varies in 
penetration depth, resolution and application.
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Confocal Microscopy
Confocal Microscopy can be used as a stand alone technique or more specifically with 
fluorescent markers. The latter allows mapping of the relative distribution of specific 
molecules throughout cells and tissues.
In contrast to wide-field optical microscopy where the whole sample is illuminated 
simultaneously, confocal microscopy uses a focused beam of light to raster across the 
sample. Because the technique uses focal point scanning, the depth of analysis can be 
altered. By performing multiple depth scans of a sample using this technique it is 
possible to form high resolution 3-dimensional images of microscopic scale biological 
structures. The basic instrumental setup of a confocal microscope is shown in figure 1.2.
Conventional confocal microscopy can image both fixed and living specimens to a 
depth of approximately 200 pm, but with new developments of passive pre-dispersion 
compensation systems, the penetration depth can be extended to 800 pm.7 In research 
confocal microscopy is often applied in assessing morphological changes in cell and 
tissue structures as well as mapping molecular expression through fluorescence 
microscopy.8,9
In medical applications the use of confocal microscopy is investigated as an endoscopic 
imaging technology. Using this technique, high resolution cross-sectional images of the 
gastrointestinal epithelium can be obtained. It is hoped that this approach may provide 
a means of direct tissue diagnosis, reducing the need for further biopsy screening.10
9
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Figure 1.2 Setup of a Laser Scanning Confocal Microscope
The laser beam is focussed into the sample. Electronic lenses and appertures are used to 
ensure that only fluorescent light from the focal plane is allowed to reach the 
photomultiplier and be detected. Fluorescence is only detected from small areas of the 
sample (the confocal point). The sample is scanned to produce a full fluorescence 
image. Because of the focal point scanning method employed, the penetration depth of 
analysis can be altered and 3 dimensional images can be produced.11
10
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Two-photon Microscopy
Similar to confocal microscopy, two-photon microscopy can also be used to study cells 
in their natural environment. Two-photon microscopy is another non-invasive optical 
imaging technique that has the benefit of greater depth penetration than confocal. The 
increased depth penetration is achieved through reducing light scattering by use of 
longer wavelengths in the excitation process.12 Conventionally tissue depth penetration 
is in the region of 700 pm, ' but this may be increased to 1mm by using a 
regenerative amplifier.17 As such this method of analysis is conventionally used to 
assist in research of in vivo studies on small animal models.
Two-photon microscopy, like confocal imaging, can incorporate fluorescence to allow 
specifically targeted analysis. Injection of dyes into the blood stream for vascular 
labeling can allow measurement of blood flow to organs.14, 18 Labelling of specific 
components such as proteins or genes can allow mapping of cell migration and gene 
expression. Cells may also be labeled ex vivo and introduced back into animal models 
for study.19
11
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Fluorescence and Bioluminescence Imaging
As already described, fluorescent and bioluminescent techniques are used as an 
investigative measure for in vivo studies. For the most part they are confined to 
laboratory research applications. These techniques are widely applied in studying 
animal models of human disease, in assessing pathological effects of pharmaceuticals 
on target tissues and for evaluating in vivo pharmacokinetics and drug target binding 
affinities.
Fluorescence imaging involves the detection of photons emitted when a fluorophore 
interacts with an incident photon. The wavelengths of the photons emitted when a 
fluorophore electron returns to the ground state are specific to the given fluorophore 
entity.
Fluorescent probes can be used to label single or multiple molecular species. 
Antibodies are targeted to molecular analyte components and then conjugated with 
fluorescent molecular labels. Multispectral fluorescence imaging can be carried out 
where several molecular species can be detected in the same image. This is achieved by 
use of a number of discrete antibody targets each with specific fluorescent label 
conjugates. The various fluorescent tags are distinguished by a change in colour in the 
final image through means of the difference in emission wavelength o f each given 
flourophore.
12
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Fluorescence microscopy is often carried out by means of wide-field, two-photon 
emission or confocal microscopy. With the high image resolution, rapid acquisition 
timescale and three dimensional abilities of the confocal and two-photon emission
microscopy approaches, this technique holds the potential for dynamic live-cell
20imaging.
Bioluminescence imaging (BLI) enables the visualisation of genetic expression and 
physiological processes at the molecular level. It is widely used in the study of tumour 
cell growth and clearance; in assessing the effects of chemotherapeutics on tumours;21 
in tracking immune system cells, in observing bacterial22,23 and fungal infections24; and
9 Cin tracking gene expression in living animal models.
Like fluorescence, BLI measures the emission of visible photons at specific 
wavelengths. In this technique however, no external light source is required. Photons 
are emitted as a result of energy dependant reactions catalysed by luciferase enzymes on 
the luciferin substrate. In contrast to fluorescence imaging, there is no background light 
signal emission from naturally fluorescent entities. This means that BLI can detect light 
emission at a much lower level. The luciferin substrate is incorporated into cells, 
organisms and genes through the process of genetic transfection. Consequently BLI is 
unlikely to find application in human studies.
13
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Both fluorescence and bioluminescence imaging are often employed in small animal 
studies, using a continuous wave light source (for fluorescence imaging) and a charge- 
coupled device camera. Localisation of fluorescent or bioluminescent emissions can be 
obtained to penetration depths of ~7mm (fluorescence) to ~3cm (bioluminescence). 
As the proximity of contrast agents to the surface affects signal intensity, these 
applications may only realistically be regarded as a semi quantitative measure.
1.2.3 Single Photon Em ission Computed Tomography
Single photon emission computed tomography (SPECT) is used as a diagnostic 
technique. It is based on the principles of conventional nuclear imaging, where a 
radionuclide is introduced into the body. A scintillation detector is used to record 
tomographic images of radionuclide distribution. The radionuclides are often bound to 
a complex that will act as tracer within the body. These complexes are specifically 
targeted toward the type of tissue or cells to be assessed.
In terms of application, SPECT is used primarily for measuring blood flow to the brain, 
heart and other organs. It can provide a more informative diagnosis of ischemia and 
organ function than can be obtained using MRI. In more detailed research applications 
SPECT is used to map brain metabolism and function.27 SPECT has also been assessed 
for the application of evaluating post-operative organ function.28
14
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In laboratory research applications SPECT is often used to assess the viability of new 
therapeutic agents. The use of therapeutic agents evaluated by this method tends to be 
those which affect blood flow to organs and/or neuronal function.29 Alternatively it 
may be used to map the targeting specificity of a therapeutic agent by nuclide labeling 
of the drug itself.30
1.2.4 Positron Em ission Tomography
Positron emission tomography (PET) is a nuclear medicine medical imaging technique
that can be used to produce three-dimensional images of various functional processes
within the body. It is often used in oncology to map tumours and metastases and make
1decisions about treatment and prognosis. It is also used as a method to evaluate 
various neurological diseases.32 Recently the use of PET has been evaluated for 
investigating rheumatoid arthritis.33 In research PET is used as an investigative measure 
for clinical trials to assess the changes induced by therapeutic interventions such as anti­
cancer drugs. It can be used to trace gene expression, angiogenesis and apoptosis.34
15
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The method is based on the observance of short-lived radioactive tracer isotopes. As 
the radio isotope undergoes decay, positrons are emitted. These collide with local 
electrons to produce a pair of gamma photons. It is these photons that are detected by a 
photomultiplier to produce a response signal. Instrumentation for PET imaging carries 
resolutions of approximately 5 mm. Recent advances have increased the resolution to 
in the region of 1 mm. This is of particular benefit in clinical resaerch where high
•5 Cresolution images are required for applications such as small animal brain imaging.
1.2.5 W hole Body Autoradiography
Whole body autoradiography is very similar to other radionuclide imaging technologies. 
It differs in the fact that images of the pattern of nuclide decay emissions are produced 
on an x-ray film or nuclear emulsion as opposed to a digital image. This technique is 
used in evaluation of natural metabolic pathways and also in the metabolism of 
therapeutic agents.
For studies of metabolic pathways, radiolabelled transport; enzyme; or receptor 
inhibitors are often administered to small animal models. These can be used to localise 
or determine changes in metabolism. In terms of assessing drug metabolism and 
evaluating drug targeting, therapeutic compounds are radiolabeled and administered to 
small animal models.
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For the process of whole body autoradiography, whole body sections of deceased 
animals are subjected to analysis. The pattern of radionuclide emissions can be 
quantitative for the distribution of the radiolabelled components. Whilst this technique 
can provide quantitative information about the localisation of a drug or metabolic effect, 
it may not possess sufficient specificity to discriminate between a drug and all o f its 
metabolites.
1.2.6 M ass Spectrometry Imaging
Mass spectrometry imaging is very different from any of the techniques previously 
described. Not only may it allow simultaneous mapping of a broad spectrum of 
biological and chemical entities, it can in most cases achieve this without the need for a 
target labeling procedure. It has the ability to identify molecules over a broad mass 
spectrum with high sensitivity and molecular specificity.
There are several means of acquiring a mass spectrometric image that are defined by the 
mode of ionisation from a solid state sample employed. These techniques are still in the 
development phase for application as imaging technologies and differ in mass range, 
sensitivity and image resolution.
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Conventional mass spectrometry is used in both routine and research applications of 
biotechnology, drug discovery, environmental health, chemical engineering and clinical 
diagnostics. It is an invaluable analytical tool which is used to measure the mass of 
molecular and elemental ions and the intensity of their signal. It is applied in studies of 
molecular characterization and structural elucidation, and is also used for qualitative and 
quantitative assessment of sample compositions.
The basic principle of mass spectrometry is defined by the ionisation of elements or 
molecules and their separation and detection according to charge and molecular or 
atomic mass.
Mass spectrometers can be divided into three fundamental parts, the ionisation source, 
the mass analyser, and the ion detector. These are illustrated in figure 1.3.
Ionisation Mass Detector
Source Analyser
Inlet------►
Figure 1.3 Diagram of a Simple Mass Spectrometer
Samples are introduced into the ion source where they undergo the process of 
ionisation. The ions are then accelerated into the mass analyser where they are 
separated on the basis of their mass (m) to charge (z) ratio (m/z). The separated ions are 
detected and the m/z information as well as the signal intensity is recorded.
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Advances in desorption ionisation techniques from a sample surface has allowed mass 
spectrometry to be applied as an imaging technique.37'39 Mass spectrometry based 
surface analysis has become an important technique in materials science. It was first 
introduced in the biological field using secondary ion mass spectrometry and has more 
recently begun to employ the use of matrix assisted laser desorption/ionisation as well 
as other newly developed ionisation techniques.
Mass spectrometry imaging will form the focus of this thesis. In the remaining sections 
of this chapter the fundamental aspects of mass spectrometry imaging techniques are 
examined and the practical considerations associated with the application of each 
approach are evaluated.
1.3 Ionisation and Mass Analysis in Mass Spectrometry Imaging
The biological application of mass spectrometry imaging has advanced significantly 
over the last decade. It is becoming an important tool for studying the distribution of 
various target compounds in cells and biological tissues.40,41
Secondary ion mass spectrometry (SIMS) and matrix assisted laser 
desorption/ionisation (MALDI) are the two main ionisation techniques currently 
employed in mass spectrometric imaging studies. Both allow ionisation and detection 
of biologically significant entities in solid state biological samples.
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The definition between the two techniques relates primarily to application. Where 
SIMS imaging can be used to determine distributions of elements and small molecules 
(<1000 Da) at high spatial resolution, MALDI-MS imaging provides a similar 
assessment of larger molecules (<100 000 Da) under lower spatial resolution (in the 
order of 50-200 microns).
Other more recently introduced ionisation techniques with the potential to be applied in 
mass spectrometric imaging include desorption electrospray ionisation (DESI) MS, 
direct analysis in real time (DART) MS, desorption/ionisation on silicon (DIOS) MS 
and matrix enhanced (ME) SIMS. DESI and DART techniques allow analysis of 
tissues under atmospheric pressure. Both methods are being examined in their 
application for mass spectrometric imaging.
Whilst DESI is primarily investigated as a diagnostic technology for medical 
application, it has also been investigated as a tool for imaging.42 DART’s current 
applications tend to lean more toward analysis of pharmaceuticals and explosives. As 
yet there is little evidence of its application as a mass spectrometric imaging technology. 
ME-SIMS is an extension of the conventional SIMS approach which utilises MALDI 
matrices to enhance the mass range of analysis whilst simultaneously retaining the 
image resolution capabilities of conventional SIMS.
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Whilst there is potential for innovative ionisation methods such as DART and DIOS to 
be applied in the mass spectrometry imaging field, these techniques are currently only 
in the very early stages of development and are not yet widely regarded as imaging 
technologies. SIMS, MALDI and (to some extent) DESI are the main ionisation 
techniques applied in mass spectrometry imaging. The remainder of this chapter looks 
at the principles of these three techniques with particular emphasis on MALDI.
1.3.1 SIMS Imaging
SIMS is commonly used to provide nanoscale metallurgic evaluation of the optimisation 
and consistency of the composition of semi-conductors and other alloy metals. Whilst 
this remains the primary application of the technique, since the 1970’s it has been 
investigated for application in organic analysis.43
SIMS imaging has made advances toward biomedical application through the analysis 
of the fragment ions of biologically important molecules.44 This has largely been made 
possible through the advent of liquid metal ion guns (e.g. gold and bismuth cluster ion 
guns).45 LMIGs have a higher focusing capacity than either of the other primary ion 
sources available. They have increased the lateral resolution of SIMS to the submicron 
level. LMIGs are also less energetic than the other primary ion beams. This makes 
them more useful in biological analysis. The use of LMIGs enhance the intensity of  
primary ion species and extend conventional SIMS mass range to in excess of 1000 
Daltons 46
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SIMS has been applied in the imaging analysis of some low mass compounds. Recently 
it has been shown to define the distribution of cholesterol in tissue.47 It has also found 
application in determining the distribution of pharmacological compounds at the 
cellular level. This has been achieved by localisation of chemical elements of the drug
48structure (i.e. halogens). SIMS analysis of isotopically labeled compounds has also 
been found to be effective. This method has been successful in determining the 
metabolism of a sodium bicarbonate in coral.49
SIMS uses a high energy primary ion beam to create secondary ions from a sample 
surface. The sample is bombarded with an ion beam creating a sputtering effect at the 
sample surface leading to the emission of sample components. A small proportion of 
the sample molecules that are ejected from the sample surface become ionised during 
this process (figure 1.4).
Beam of secondary Ions 
to be analysed
Extraction lens
Primary ion beam
Secondary ions
Sample
Figure 1.4 Principle of Secondary Ion Mass Spectrometry
The primary ion beam is focused at the sample surface. The high energy impact of the 
ion beam leads to sputtering and ejection of the surface of the sample. Some of the 
particles become charged during the process. These charged molecules are extracted 
into the mass spectrometer for analysis.
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There are several classes of primary ion sources that can be used in SIMS instruments. 
These include duoplasmatrons which create primary ions from gaseous elements (e.g. 
noble gases or oxygen) or molecules (e.g. SF5+ or C6o+); surface ionisation sources 
which create cesium ions by vapourisation of cesium through a porous tungsten plug; 
and liquid metal ion guns (LMIG) which generate primary ions from liquid state metals 
and alloys under the influence of an electric field.
The focusing capacity of ion beams is much greater than that of the laser beams used in 
MALDI. As a consequence, SIMS can map the distribution of sample components at a 
much greater image resolution. SIMS does however, have a limited mass range as the 
high energy involved in ionisation leads to extensive fragmentation. As such, this 
technique is applied in the study o f the distribution of atoms and low mass molecules. 
Because of the high mass and atomic heterogeneity of many biological components, this 
technique often requires analytes to be naturally or synthetically labeled with a 
distinctive atomic entity. This technique has however been successful in allowing the 
analysis of both elemental and molecular distributions in cells.50'52
The use of matrices in SIMS imaging has also been investigated. This matrix enhanced 
SIMS (ME-SIMS) technique uses an organic acid to increase the conventional SIMS 
mass window to approximately 2500 Da.53 This technique has been shown to provide 
images which maintain the high image resolution of SIMS (<lpm ), whilst 
simultaneously allowing (to some extent) the attribute of MALDI-MS extended mass 
range.54
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1.3.2 MALDI-MS Imaging
Matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) was 
introduced as a molecular imaging technique in the late 1990’s.40 This ‘soft’ ionisation 
technique allows analysis of intact molecules over a much broader mass spectrum than 
SIMS. Where SIMS imaging tends to rely on determination of fragment ions related to 
biological entities (such as phospholipids for example),44’ 55 in MALDI-MS these 
molecules are ionised intact. This can provide a more informative mode of analysis, 
where the heterogenous distribution of distinctive phospholipids can be defined.56
MALDI-MS imaging has been applied to the analysis of a number o f different classes 
of compound. It is most widely used for protein analysis 40,57'61, but has also been used 
for the analysis of pharmaceuticals62, 63, agrochemicals64 and other low molecular 
weight compounds such as endogenous metabolites 65,66.
The principle of MALDI was adapted from the technique of laser desorption. This 
technique involved the dissociation of thermally labile bonds. MALDI was first 
introduced as a method of analysing large biomolecules by using an inorganic matrix.67 
It was further developed by Karas and Hillenkamp with the use o f organic acid matrices
O Dfor the analysis of involatile compounds.
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In MALDI-MS molecules are ionised by means of pulsed laser desorption from a solid 
state sample under high vacuum. The ionisation process is reliant upon a matrix 
(usually small organic molecules) that strongly absorbs energy at the laser wavelength. 
The energy absorbed by the matrix ultimately drives the matrix crystals and associated 
molecules into a gaseous phase matrix-analyte plume. There is much less energy 
imparted to the analytes than there is in the older method of laser desorption, hence it 
being defined as a soft ionisation technique.
The ionisation reactions that occur in MALDI are not yet fully understood. The most 
widely accepted mechanism for ionisation is through gas-phase proton transfer between 
photoionised matrix molecules and analytes in the matrix-analyte plume. The process 
of this reaction is illustrated in figure 1.5.
The latest advances in increasing MALDI-MS image resolution have been introduced 
by the combination of laser mass microprobe mass analysis and MALDI. A current 
limitation associated with this technique is that the lateral resolution of image 
acquisition exceeds that of the current means of matrix application. 68
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Figure 1.5 Diagram of the principle of MALDI
Laser irradiation leads to desorption of matrix and analyte into an expanding gas phase 
plume. Gas phase proton transfer occurs between the analyte and photoionised matrix 
molecules.
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1.3.2 DESI Imaging
Desorption electrospray ionisation (DESI) is a relatively new technique that can be used 
as method of ionisation for mass spectrometric imaging. DESI uses a solvent 
electrospray directed at a sample surface to desorb ions for introduction into the mass 
spectrometer (figure 1.6). DESI is very different from SIMS and MALDI as ions are 
generated under ambient pressure.69
This technique remains in its infancy and there is currently only one report of producing 
images using this technique in the literature, but DESI has benefits over MADLI and 
SIMS as it allows for rapid analysis with no sample preparation. It has been used to 
analyse pharmaceutical samples such as tablets, ointments and liquids, and as such it 
has been shown to allow rapid automated screening of drug tablet constituents.70
In the imaging experiment published DESI was used for assessing the distribution of a 
number of fatty acids in brain tissue, image resolutions were reported to be in the region 
of 500 microns with unit mass resolution.71
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Freely Moving 
Sample Stage
Figure 1.6 Desorption Electrospray Ionisation
A solvent under electrospray is directed at the sample surface and ions are desorbed. 
The ions are then introduced into the mass spectrometer for analysis.72
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1.3.5 M ass A nalysis in M ass Spectrometry Imaging
In mass spectrometry imaging ions are usually separated using a time o f flight (TOF) 
mass analyser. TOF mass analysers have almost unlimited mass range and are 
amenable to pulsed modes of ionisation. This makes them ideal for analysis of large 
biomolecules and analysis of ions generated through the various desorption/ionisation 
techniques employed in imaging. The TOF mass analyser consists of a field free drift 
tube, through which ions travel to the detector.
Charged particles are introduced into the field free drift region as a pulse by application 
of an acceleration potential. At this point the kinetic energy of charged particles is 
equal between ions of like charge. The difference between the velocities of ions is 
measured by the time at which they reach the detector. The velocity of each ion is 
defined by the mass to charge ratio, where smaller ions will travel faster than larger ions 
with the same charge. The process of TOF separation is given in equation 1.
— = 2 eEs ' t *
\ u j
Equation 1 The Equation of TOF Separation
The mass to charge ratio of the ion is defined by m/z, where E  is the extraction pulse 
potential, s is the length of the flight tube over which the extraction pulse is applied, d  is 
the length of the field free drift region and t is the time of flight measured for the ion.
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Although TOF separation is a highly sensitive technique, there remains energy 
dispersion between ions of like m/z. This can be more prominent with ionisation 
sources where ions have been produced in an expanding plume. The kinetic energy 
spread of like ions can be resolved through introduction of a means of kinetic energy 
correction. One method of correcting discrepancies in kinetic energy spread is to 
introduce a short time delay after the ionisation event, before ions are extracted into the 
mass analyser. Delayed extraction allows less energetic ions to gain more kinetic 
energy in the source, such that ions of like m/z ratio become more focused at the 
detector plate. This is illustrated in more detail in figure 1.7.
High voltage source
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Figure 1.7 Schematic Representation of Delayed Ion Extraction
In delayed pulsed extraction mode ions of a given m/z with correct kinetic energy (red) 
spend a shorter time in the source than those of the same m/z with less kinetic energy 
(blue). The energy dispersion between the like ions is corrected as those spending 
longer in the source gain more kinetic energy.
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Another method of increasing the mass resolution of TOF analysers is to use an 
electrostatic reflector (figure 1.8). A reflectron, as it is more commonly known, consists 
of a series of grids and ring electrodes which act as an ion mirror. In contrast to the 
linear TOF configuration previously described, a reflectron TOF redirects ions back 
through the flight region of the analyser. Kinetic energy dispersion between like ions is 
corrected as ions with greater kinetic energy penetrate further into the reflectron region. 
By retarding ions of greater kinetic energy for a greater length of time than those with 
less kinetic energy, discrepancies in the time of flight of ions with the same m/z ratio are 
resolved. Similar to the effect of delayed extraction, this provides increased mass 
resolution, as ions of like m/z ratio reach the detector at the same time.
Linear 
detector
Figure 1.8 Reflectron TOF Mass Analyser
Like ions enter the mass analyser with different kinetic energy. Ions with greater 
kinetic energy penetrate further into the reflectron region than those of lesser kinetic 
energy. This allows for correction of the kinetic energy dispersion such that ions of like 
charge and mass reach the detector at the same time.
Reflectron
Field free 
drift zone
Reflectron
detector
31
Chapter 1
TOF mass spectrometers are commonly used in conjunction with quadrupole mass 
filters, where the quadrupole is positioned as the first mass analyser. In normal MS 
mode the quadrupole acts an RF only focusing device.
A quadrupole (Q) mass filter consists of four parallel metal rods with elliptical, circular 
or hyperbolic section. Each pair of opposing rods is given an equal fixed applied direct 
current voltage, with each o f the two pairs of rods having contrasting polarity. An 
alternating radio frequency (RF) potential is superimposed onto the direct current 
voltage. Ions pass through the centre of the quadrupole, their trajectories defined by 
electric fields. By alternating the RF applied, ions of different m/z are brought into 
focus.
In a hybrid Q-TOF instrument, the quadrupole can be used to select ions of specific m/z 
ratio for a second MS analysis. The selected ions are subjected to collision induced 
dissociation and the resulting product ions assessed by the TOF mass analyser. Product 
ion scans are useful for chemical characterisation. They can also be used to enhance 
sensitivity as a product ion can allow differentiation between precursor ions of like or 
unresolved m/z ratio. A schematic diagram of a hybrid quadrupole mass spectrometer is 
shown in figure 1.9.
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Figure 1.9 Schematic of Applied Biosystems/MDS Sciex Q-Star Pulsar i
A schematic diagram of an Applied Biosystems/MDS Sciex Q-Star Pulsar i hybrid 
QTOF LC/MS system with delayed pulse extraction and reflectron.73
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1.4 Mass Spectrometry Imaging Processes
The process of mass spectrometry imaging can be divided in to various stages; sample 
preparation; image acquisition; and image processing. Here, the stages are explained in 
more detail along with methods of statistically evaluating image data.
1.4.1 Sam ple Preparation in M ass Spectrometry Imaging
Sample preparation is perhaps the most important step in MS image analysis. Poor 
sample handling can cause serious degradation in the integrity of the sample.
In SIMS imaging, the preparation of samples is dependant of the type o f sample used. 
For tissue analysis, the sample is sectioned using a cryostat. For cell culture analysis, 
samples are cryogenically preserved and freeze fractured to expose intracellular 
contents. Samples may then be stored under high vacuum to avoid exposure to moisture 
that may induce analyte migration. This is particularly important with the high image 
resolution of SIMS, where very small amounts of moisture may lead to significant 
degrees of analyte migration within the sample.74 Gold sputter coating o f the sample is 
often carried out prior to SIMS analysis. This is found to enhance the conductivity of 
the sample and increase the sensitivity of analysis.75
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MALDI-MS image samples are usually biological tissue sections. These are produced 
on a cryostat in the absence of embedding medium to avoid suppression of analyte 
signals 60. Samples are often washed in several gradients of ethanol to remove residual 
salts. This serves to enhance matrix crystalisation.59,60
Tissue sections are coated in an organic acid solution in preparation for MALDI 
analysis. Application of the matrix is an extremely important stage o f the preparation 
procedure. The matrix has to be applied in a way that allows sufficient interaction 
between the analytes and matrix solvent, yet avoids any extensive wetting of the sample 
that might induce analyte spreading. This can be achieved in a number of different 
ways. Electrospray deposition76, air-spray deposition or nebulisation58,60,77 and nano­
scale matrix spotters have been used.78 The choice of matrix solvent can be pivotal to 
the sensitivity of the analysis. The solvent must take into account the solubility of 
analytes as well as the matrix.79 As with SIMS imaging, samples are sometimes sputter- 
coated in gold to enhance sensitivity and reduce the surface charging effect that can lead 
to distortion of ion images.80
Advances in sample preparation will be critical in allowing higher resolution MALDI- 
MS image analysis. Optimisation of matrix solvents and the use of nanoscale matrix 
deposition devices has already been demonstrated to increase the sensitivity of analyte 
detection and reduce the degree of analyte spreading respectively.60,78,81
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ME-SIMS is a new adaptation o f the conventional SIMS approach that includes the use 
of organic matrices in a similar manner to MALDI experiments. This method of 
analysis yields comparable results to those found with MALDI-MS imaging up to 
masses of approximately 2500 Da. The advantage of applying SIMS to a sample 
prepared with a MALDI matrix is that images can be acquired with a much higher 
spatial resolution (between 60 and 500 nm) than can be obtained in conventional 
MALDI-MS imaging.
1.4.2 M ass Spectrometry Im age Acquisition
The analytical apparatus required to produce mass spectrometric images is similar to 
that used in the relevant conventional mass spectrometric technique. The 
instrumentation and software is adapted slightly to allow the sample plate to be moved 
at set increments beneath the ion or photon beam. As the ion or photon beam is rastered 
across the sample surface, a mass spectral analysis is performed at a series of pre­
determined points. The mass spectrum acquired at each point is recorded along with the 
relative x,y co-ordinate and these data are then used to build an ion image. Figure 1.10 
illustrates the process of mass spectrometry image acquisition.
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Ion Beam/ Incident Photon
m/z
Figure 1.10 Mass Spectrometry Image Acquisition
The sample plate is moved at set increments beneath the stationary ion or photon beam. 
A mass spectrum is acquired at each point and recoded with its x,y  co-ordinate.
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In this mode of analysis, known as mass microprobe mode, the confines of image 
resolution are defined by the laser spot diameter, although over-sampling can be carried 
out.
Recently a new method of acquiring MALDI-MS images has been described, known as 
the mass microscope. Position-correlated ion detection is used to generate an ion 
image of approximately 4pm resolution from a single stationary laser ablation spot on 
the sample surface. By scanning across the sample surface, a number of ion images can 
be produced (figure 1.11). These can be pieced together to form a high resolution ion 
image o f the sample.
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Ion Beam/ Incident Photon
Mass microscope ion images are
Figure 1.11 Acquiring ion images in mass microscope scanning mode
As the laser passes across the sample surface a mass microsope image is acquired at 
each point. The ion images are concatenated to produce a high resolution ion image of 
the sample surface.
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1.4.3 Im age Processing
The data acquired during MS image analysis are sorted computationally by m/z ratio, 
ion intensity and x,y co-ordinate. Imaging software is used to digitally scan through the 
data to obtain the ion intensities recorded for a defined m/z range or m/z value. The 
intensities found for the mass range or value selected are displayed in a two dimensional 
plot, where ion intensity is shown on a linear scale by a change in brightness or hue for 
each x,y co-ordinate or pixel. The pixel size is determined at the time of analysis, where 
the plate stepping measurements are defined by the user. Limitation of the level of 
image resolution is largely defined by the laser or ion beam diameter.
1.4.4 Statistical Evaluation o f  M ass Spectrometry Image Data
The data acquired in mass spectrometry imaging can be difficult to interpret, and hence 
a number of statistical approaches have been employed to compress, de-noise and 
determine patterns in the hyperspectral data. Statistical techniques conventionally 
applied to enhance the quality of many types of digital image data have been assessed 
for their application in mass spectrometry imaging. Principal components analysis 
(PCA), discriminant analysis (DA) and factor analysis (FA) have been used to extract 
localised variation in ion abundance using the ion intensities recorded in the image mass 
spectra.83,84 Other statistical methods have also been applied to PCA treated data which 
function to maximize the variance attributed to each of the principal components.85
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Images are produced using the principal component scores for each individual pixel. As 
such, the quality of the final image is considerably enhanced and it is possible to 
classify tissue types by spectral pattern as opposed to a single ion.83
1.5 MALDI-MS Imaging Research
MALDI mass spectrometry imaging holds great potential for application in biomedical 
research. The capacity to simultaneously profile and map the distribution of molecules 
in situ has led to widespread interest in the technique by academia and industry alike. 
The unparalleled ability that MALDI-MS holds for detecting a large number of 
molecules simultaneously from a tissue surface makes it an attractive alternative to 
many of the conventional molecular imaging methodologies that are currently employed 
in research.
The initial experiments in MALDI-MS imaging were carried out by the Caprioli group 
in the late 1990’s. Here, the technique was first promoted for its ability to detect protein 
and peptide signals directly from tissues sections. It was observed that tissue types 
could be distinguished by the unique signal profiles observed. It was also found that 
there was a high level of homology in the profiles taken from tissues of genetically 
similar mouse strains. The direct analysis of tissues by MALDI-MS has since been 
applied to much greater extent, with successful detection of peptide and protein signals 
from a broad range of different tissue types.40,87'89
41
Chapter 1
The technique has more recently been extended to the analysis o f other molecules such 
as small metabolites65, 66 and pharmaceutical compounds.62, 90, 91 With particular 
emphasis being placed on the application of MALDI-MS imaging in the study of the 
pathogenesis and treatment of disease, analysis of smaller molecules is an extremely 
important development for extending MALDI-MS imaging analysis into the clinical 
field. Promotion of MALDI-MS image analysis as a method of pre-clinical assessment 
has been influenced by the successful analysis of whole body sections like those used in 
whole body autoradiography.92'95 With these images it is not only possible to pinpoint 
the distribution of drugs inside the body of the dosed animal, but it is also possible to 
differentiate between the drug and its metabolites in situ, a major limitation associated 
with whole body autoradiographic analysis.
With the fundamental aspects of MALDI-MS imaging in place for the analysis of a 
wide variety of molecules and tissues, research has now become directed toward how 
best to optimise the imaging approach. This is being done in several areas, primarily in 
sample preparation, but more recently it has emerged that data normalisation is an 
important aspect as well.96
The need to optimise and regulate the image sample preparation process has been a 
source of extensive research. Several publications stress the importance of sample 
preparation on the quality of image results. These relate to sample handling, various 
sample treatments60 and perhaps most prominently to matrix application. For the latter, 
the outcome has been the development of several automated matrix deposition 
devices.78,81
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Currently many of the MALDI-MS imaging reports have been directed toward the 
analysis of specific molecular targets. In order to utilise all of the information obtained 
during MALDI-MS image analysis, several research groups have begun to look deeper 
into methods of data interpretation. A number of methods have been proposed as ways 
of statistically sorting through the vast amounts of data. These include principal 
components analysis and multivariate cluster analysis.83
Some of these areas of MALDI-MS imaging research that are directed toward 
optimizing the method are investigated in this thesis. More in depth discussions of the 
current research associated with each area is presented as the introduction to each 
experimental chapter.
1.6 Aims of Work
The work carried out in this thesis is based on the imaging of small molecules by 
MALDI-MS. Experiments are focused toward assessing the fundamental aspects of 
MALDI-MS imaging in this area of applications. The application of a high repetition 
laser is evaluated for use in MALDI-MS imaging experiments. The various methods of 
data normalisation conventionally used in MALDI-MS imaging are compared and a 
new method is investigated. Optimisations of sample preparation procedures for both 
direct and indirect imaging of biological tissues are assessed and the use of principal 
components analysis is evaluated for application as a latent variable determinant from 
the hyperspectral datasets.
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2 Evaluation of a High Repetition Nd:YAG Laser
2.1 Introduction
The fundamental principle of the MALDI process is based on the irradiation o f matrix 
crystals and associated analytes through application of a laser beam. A laser is a 
mechanical device that is used to produce coherent radiation.
The term ‘laser’ is an acronym for Light Amplification by Stimulated Emission of 
Radiation. A laser works via excitation of gain medium atoms and their release of 
photons at specific wavelengths as they return to their ground state.
The wavelength of the laser is governed by the gain medium used in the laser system. 
The gain medium may be a liquid, gas, solid or semiconductor material. There are 
many gain media that have been employed in laser operation, all of which function to 
stimulate emission of photons leading to the amplification of light.
By using mirrors, photons are forced to make many passes through the gain medium 
contained within the optical cavity. As they do so, they stimulate other excited atoms to 
emit photons of the same frequency and direction. As the photons make multiple passes 
through the gain medium, the power of light is amplified before being allowed to pass 
through a partially transparent region in one o f the mirrors to form the laser beam. The 
wavelength of light emitted from the laser is governed by the gain medium used in the 
laser system.
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The majority of MALDI-MS analyses are conducted using organic acid matrices. These 
matrices absorb light in the UV range of the visible light spectrum. UV laser desorption 
of organic acid matrices was introduced by Karas and Hillenkamp in the late 1980’s as a 
useful means of allowing the analysis of large biomolecules by mass spectrometry.1'3 
The UV lasers conventionally used in MALDI-MS are nitrogen (X=337nm) and 
frequency tripled or quadrupled Nd: YAG (A^=355nm or 266nm) UV lasers.
The majority of MALDI-MS instruments have been designed for use with nitrogen 
lasers. This has primarily been due to the reduced cost and increased availability of 
nitrogen lasers in comparison to Nd:YAG lasers. Nitrogen lasers can have repetition 
rates up to approximately 50Hz and have a lifetime of approximately 2 x l0 7 to 6 x l0 7 
shots.4 In this chapter a frequency tripled (X=355nm) NdrYAG laser is assessed for 
MALDI-MS imaging. The benefits of NdiYAG lasers lie with the high repetition rate 
and the extended laser lifetime. These lasers can readily achieve repetition rates up to 
lKHz, with a lifetime of several 109 shots.4
Recently with MALDI applications extending into LC-MALDI and MALDI-MS image 
analysis, high throughput and extended laser lifetimes are important factors to be 
considered. Image acquisition with N2 lasers typically runs at approximately 100 shots 
per pixel. This would mean that for an image run of 100x100 pixels, 1 million shots 
would be used.
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Taking in to consideration the extended lifetime and laser repetition rate, NdiYAG 
lasers are an attractive alternative to nitrogen lasers for MALDI-MS imaging 
experiments. The laser pulse frequency has been found (in conventional MALDI-MS 
analysis) to increase sample throughput whilst providing spectra of equal quality to 
lower repetition rate lasers, but with the benefits of greater reproducibility and shorter 
acquisition times.5
Nd:YAG typically emit in the infrared region of the visible light spectrum at a 
wavelength of 1064nm, but with frequency doubling, tripling and quadrupling, 
wavelengths of 532nm, 355nm and 266nm can be produced. The wavelength of 
frequency doubled and tripled Nd:YAG lasers fall within the UV region o f the visible 
light spectrum. These laser configurations can therefore be applied in MALDI-MS 
analysis.
The effects of laser properties on the desorption process in MALDI have been studied 
by various research groups. In the studies conducted, the main focus of interest tends to 
be the laser wavelength, the laser pulse width, the laser fluence (or radiant exposure) 
and the profile of the laser beam.
The laser wavelength is an important factor in MALDI analysis, with the MALDI 
process being fundamentally reliant upon this property for absorption of energy by the 
matrix crystals. Small changes in laser wavelength are seen to have effects on sample 
ionisation with certain matrices. For example, it has been noticed that matrices such as 
sinapinic acid and 3-hydroxypicolinic acid provide a much lower response with an 
Nd: YAG laser than is observed when using a nitrogen laser.4
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Laser pulse width and laser fluence are features which have also been subject to 
investigation in relation to MALDI analysis. In UV-MALDI-MS, laser pulse widths of 
0.5-10 nanoseconds are typically employed. These short laser pulse widths are thought 
to avoid the destructive thermal excitation of analyte molecules that are observed with 
longer pulse widths and which can lead to fragmentation.6
The laser fluence is defined as the laser energy per unit area incident on the sample 
surface. This parameter is of extreme relevance in MALDI-MS as it plays an important 
role in the yield of desorbed ions and molecules.7 Like the laser pulse width, the laser 
fluence has also been linked to the level of fragmentation that can occur during the 
desorption/ionisation process.8
The typical profile of an Nd: YAG laser beam is Gaussian in shape. Recent research has 
shown that a Gaussian laser profile may influence the MALDI process quite 
significantly. This is found to be particularly important with respect to imaging, where 
laser irradiation is static at each acquisition point. This is thought to be due to a lack of 
homogeneity of laser fluence over the laser irradiation area leading to the occurrence of 
hotspots within the laser irradiation area. Efforts have been made to create a flat top 
beam profile to address this issue. In these experiments it has been found that the use of 
a flat top beam profile can increase the reproducibility of MS ion signals.9 Other 
studies have looked at the effects of modulating the beam profile, such that the laser 
profile is slightly altered for each laser pulse. This form of dynamically altering the 
laser profile is similar to the changes in nitrogen laser profile that have been observed 
from shot to shot.4
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In this chapter an Nd:YAG laser is assessed for MALDI-MS imaging. Measurements 
of the laser properties have been conducted and a number of imaging experiments have 
been carried out.
2.2 Materials and Methods
2.2.1 Materials
All MALDI-MS experiments were carried out using a Teem (PNV 001525 SC2) high 
repetition rate Nd:YAG laser (Teem Photonics, Massachusetts, USA) on an Applied 
Biosystems/MDS Sciex QStar Pulsar i (Ontario, Canada) fitted with an orthoganol 
MALDI ion source. All chemical reagents were obtained from Sigma-Aldrich (Poole, 
UK).
2.2.2 M ethods
Several methods were used to assess the application of the Teem Nd:YAG laser for 
MALDI-MS imaging experiments.
Examinations of the laser beam profile, pulse width and peak energy were carried out in 
collaboration with Dr. Keith Oaks of Elforlight Ltd. (Daventry, UK)
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2.2.2.1 M easuring L aser Spot Size
The laser spot size is an important feature of the laser in imaging experiments as its 
dimensions may govern the maximum resolution of images that may be obtained. The 
laser spot size was measured by burning lines through the matrix coating on a stainless 
steel MALDI target in the x and y dimensions. A stainless steel MALDI target was 
spray coated with a-CHCA matrix (25 mg/mL in ethanol, 0.1% TFA). With the laser 
power set to 5.0pJ the matrix coating was ablated from the target surface in a vertical 
line. On a separate area of the target the same was carried out in the horizontal direction. 
Measurements of the width (vertical ablation mark) and height (horizontal ablation 
mark) were taken on an optical microscope (Olympus CH-2 at 100X magnification).
2 2 .2 .2  L aser E nergy
The laser energy was assessed by measuring average power on a Molectron PM 10 head 
and EPM1000 display unit. Measurements were taken whilst the laser was set to a 
repetition rate of 1kHz, which is the standard pulse frequency used in imaging 
experiments. A number of measurements were made from 25% to 100% energy, 
although only briefly beyond 50% (5.0pJ) due to concerns about damage to the fibre 
optic.
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2 .2 .2 3  Pulse Width
The pulse shape was monitored on a Telefunken photodiode with a lOOps rise time, and
a 300MHz Tektronix ’scope. Measurements were taken at 25% and 40% laser power.
2 .2 .2 .4  Beam  Profile
The beam profile from the multimode fibre was recorded using a Spiricon LB3 beam 
profiler system based on a Pulnix TM6 camera. The raw beam profile from the fibre 
optic was viewed at a distance of approximately 50mm from the end of the fibre optic at 
a laser energy level of 5%. A crude attempt was made to focus the beam using a 
magnifying lens combination with a focal length approximately 40mm, this was carried 
out using a laser energy of 25%.
2.2 .2 .5  A ssessing the Effect o f  L aser P rofile on M ALD I Im aging
The literature suggests that hotspots and the static nature of Nd:YAG laser beam 
profiles may account for the reduced ion signals often observed in imaging experiments. 
Recently a new laser which modulates the hotspot regions within the laser spot has been 
introduced.9 Based on these facts and the results obtained from the measurement of the 
Teem laser beam profile, several experiments have been carried out to assess the effects 
of moving the position and/or modulating the laser profile at each pixel during image 
acquisition.
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In normal (static) imaging mode the laser beam is fired at a single point on the sample 
surface for the pre-determined length of time. The laser is then stopped whilst the 
sample plate is realigned for MALDI-MS acquisition at the next image pixel.
In dynamic pixel imaging mode the laser beam is fired at the sample surface in the same 
way, stopping to allow realignment of the plate to the position of the next image pixel. 
However, whilst data is being acquired for each image pixel, the sample plate is 
manoeuvred in a figure of eight pattern within the confines of the pixel dimension.
Stationary versus dynamic mode imaging has been assessed by looking at the ion 
intensities observed in each mode. Text was printed in Arial font size 6 onto normal 
copy paper using a Hewlet Packard HP2420 printer fitted with a compatible black ink 
printer cartridge. The sample was coated in approximately 5 mL of a-CHCA (25 
mg/mL in ethanol, 0.1% TFA) by airspray deposition. MALDI-MS images of the text 
were acquired in static and dynamic pixel imaging modes. The sensitivity o f the 
imaging process was assessed by acquiring images at various resolutions (200, 100 and 
50 pm). Further experiments were carried out in stationary mode in which the fibre 
optic was manoeuvred manually to disrupt and vary the speckle pattern of the laser 
beam profile.
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2.3 Results
The laser model under evaluation is a Teem PNV 001525 SC2 (Teem Photonics, France) 
on loan from Applied Biosystems/MDS Sciex for evaluation purposes. This laser has 
been fitted to a QStar Pulsar i mass spectrometer. It is introduced into the MALDI ion 
source by means of a fibre optic feed and is controlled by o-MALDI server 5.0 imaging 
software. According to the manufacturers performance specifications this laser has an 
energy range of between 15 and 30pJ, a repetition rate scale from 0.01 to lKHz and a 
pulse width of 0.5ns. The laser beam profile is described as elliptical with a typical 
ellipticity ratio of 2:1.
2.3.1 M easuring Laser Spot S ize
The laser spot size measurements appear to be approximately 88+13pm in the 
horizontal dimension (figure 2.1a) and 150+25pm in the vertical dimension (figure 
2.1b). Based on these results is would appear that the manufacturers approximation of a 
beam profile elipticity ratio of 2:1 is correct.
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Figure 2.1 Measurements of Laser Spot Dimensions
Optical images (100X magnification) of linear matrix ablation paths are shown to 
illustrate the laser spot dimensions. The laser spot width (a) and height (b) dimensions 
were measured using a light microscope by looking at the ablation of matrix from a 
MALDI target surface. The width of the laser spot appears to be between 75 and 
100pm and the laser spot height appears to be between 150 and 200pm.
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2.3 .2  M easuring Laser Energy
The laser energy was measured to ensure that it correlated with the calibration values 
given in the instrument control software, i.e. 2.5pJ at 25% energy etc. Measurements 
were made from 25% to 100% energy, although only briefly beyond 50% (5 jaJ) due to 
concerns about damage to the fibre. On initial switch on, some variance in laser power 
was observed, with the variation being up to about 50% of the laser power defined by 
the software calibration. This appeared to settle down after a few minutes operation.
2.3.3 M easuring Pulse Width
The laser pulse widths appeared to be around 800ps FWHM, but this is probably limited 
by the Tektronix ’scope response time. These results are shown in figure 2.2. The laser 
manufacturer’s quoted pulse width is <500ps. Based on the results obtained and the 
limitations of the Textronix ‘scope response time, 500ps would seem reasonable pulse 
width.
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Figure 2.2 Laser Pulse Width Traces
Traces are shown at 25% (a) and 40% (b) laser energy levels. The stability of the pulse 
width is indicated by observable changes of energy levels over time. At lower energy 
levels of 5% (c) a slightly higher level of instability was observed. This can be seen in 
the above illustration as an increase in the thickness of the line indicating laser energy.
65
Chapter 2
2.3.4 Measuring Beam Profile
The profile observed from the raw beam from the fibre optic indicated a speckling effect 
(figure 2.3a). The speckling effect was still observed after crudely focusing the beam 
using a magnifying lens combination (figure 2.3b). The speckle is thought to be caused 
by interference as the beam passes through the fibre optic as a result of the high 
coherence of the laser. It was found that the speckle pattern could be varied by 
manually moving the fibre optic cable around.
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(a)
Figure 2.3 Laser Beam Profile Images
Speckle was observed both from the raw laser beam at 5% laser energy and after 
focusing the laser beam at 25% laser energy. Laser speckle with Nd:YAG lasers is a 
by-product of use of multi-mode fibre optic feed delivery systems.
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2.3.5 Assessing the Effects o f Laser Profile on MALDI Imaging
Static and dynamic pixel imaging modes were evaluated by measuring the ion signal of 
rhodamine 6G at m/z 443.5. These are compared to the results obtained by imaging in 
static imaging mode whilst manoeuvring the fibre optic cable in figure 2.4.
In dynamic pixel imaging mode, high ion yields were observed. The ion yield obtained 
in static imaging mode was significantly reduced by comparison. However, the image 
acquired in static imaging mode where the fibre optic cable was manoeuvred to vary the 
speckle pattern of the laser profile produced ion yields comparable to those obtained in 
dynamic imaging mode. This would indicate that varying the speckle pattern of the 
laser has a similar effect in enhancing sensitivity as using the dynamic pixel imaging 
mode when acquiring MALDI-MS images.
Figure 2.5 shows the images obtained using the dynamic pixel imaging mode at 200, 
100 and 50pm resolutions. It can be seen from the images that as the resolution 
increases, the ion yield is reduced. This is thought to be a result of the laser movement 
being increasingly confined as the pixel dimensions get smaller. In these experiments, 
where at a pixel size of 50pm, the ion signal from the ink becomes too low to be able to 
distinguish the letters in the image. A 50pm resolution image was acquired in which 
the laser speckle pattern was varied by moving the fibre optic cable whilst the 
instrument acquired in static imaging mode (figure 2.5d). In this image the letters could 
clearly be distinguished. This shows that at higher resolutions, varying speckle pattern 
whilst acquiring in static imaging mode produces higher ion yield than is observed in 
dynamic pixel imaging mode.
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(a)
Figure 2.4 Comparing MALDI-MS Imaging modes
Ion images produced at a resolution of 200pm for the protonated molecule of rhodamine 
6G (m/z 443.5) compare dynamic pixel imaging mode (a) with static ion imaging mode 
(b) and varying the laser speckle pattern by manouvring the fibre optic(c). Static ion 
imaging mode produces a much lower ion yield than is observed with either of the other 
two modes of acquisition.
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Figure 2.5 Assessing Sensitivity as Image Resolution is Increased
Images acquired in dynamic pixel imaging mode at resolutions of 200pm (a), 100pm 
(b) and 50pm (c) are shown. It can be seen that as the image resolution increases the 
ion yield is reduced. In a 50pm resolution image acquired in static imaging mode 
higher ion signals were observed than in dynamic pixel imaging mode when the speckle 
pattern was varied by moving the fibre optic cable (d).
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2.4 Conclusions
The laser energy and laser pulse width measurements taken for the Teem Nd: YAG laser 
are in agreement with the manufacturer's specifications. Assessment of the beam profile 
provided some interesting results. In contrast to the reported Gaussian beam profiles of 
Nd: YAG lasers4, it appears that by using a fibre optic feed to introduce the laser into the 
ion source, the Gaussian beam profile is altered to produce a speckled effect.
The assessment of the high repetition rate Nd:YAG laser for MALDI-MS imaging 
showed that dynamic pixel imaging mode produces a higher ion yield than is observed 
in static imaging mode. A similar enhancement of ion signals was observed when the 
speckle pattern was varied by manoeuvring the fibre optic cable during image 
acquisition. In this latter mode of image acquisition, higher ion signals are produced at 
50pm resolution than were obtained in dynamic pixel imaging mode. This is thought to 
be due to the fact that the movement of the laser is reduced as the pixel size becomes 
smaller.
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3 Indirect Tissue Imaging
3.1 Introduction
Conventionally, MS imaging of biological tissues relates to the analysis of compounds 
directly from the surface of a tissue. Therefore, MALDI-MS imaging samples are 
generally composed of thin tissue sections coated with an organic acid matrix. This 
method of sample preparation has been shown to be successful in the analysis of a broad 
range of analytes from a number of different tissues.1'3 It appears however that there are 
some exceptions. In this chapter some of the problems which may be encountered with 
direct tissue analysis are introduced and studies carried out to overcome these issues by 
using an indirect imaging approach are shown.
When analysing low abundance compounds from within a complex mixture it may be 
beneficial to selectively extract the compound of interest. It has been shown that 
selective extraction reduces the complexity of the mass spectrum generated and can also 
function to enrich the sample, increasing the limit of detection for the analyte(s) in 
question.4,5 Taking these factors in to account, it is not surprising that whilst attempting 
to ionise molecules from an untreated sample surface, as is carried out in many 
MALDI-MS imaging experiments looking at the distribution of xenobiotic compounds, 
the same problems are encountered.
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As with conventional MALDI analysis, tissues used in imaging experiments become 
less amenable to direct analysis when the matrix crystalisation process is hindered by 
salts within the tissue. This effect may be observed to a greater or lesser extent in 
different tissue types. It has been found that in some cases this problem can be resolved 
by introducing a series of tissue washing steps prior to matrix application.6 The salt 
content of tissues is reduced by washing the sample in increasing concentrations of 
ethanol. This procedure has been shown to be beneficial for the detection of analytes 
such as proteins and is examined in the analysis of lipids in later chapters. However, in 
the detection of analytes presenting high ethanol solubility this method may be 
detrimental to sample integrity as ethanol washing may induce migration and in extreme 
cases, complete loss of the analyte.
In this chapter, MALDI-MS imaging is investigated for the detection of a xenobiotic 
compound in porcine skin tissue. The skin is the largest organ of the body, serving as a 
barrier to xenobiotic absorption in order to protect the tissues and organs beneath its 
surface from exposure. Despite this, the skin remains an important vehicle for the 
administration of a number of drugs, both in the treatment of the skin itself as well as 
for drugs intended for systemic circulation, where it is required that the first pass effect 
is avoided. Current methodologies for the determination of dermal absorption include 
skin extraction measurements, horizontal sectioning and comeum tape stripping, 
quantitative skin autoradiography and spectroscopic methods.7'10 Problems commonly 
associated with these techniques include the requirement for radiolabelled compound, 
poor sensitivity and the loss of spatial information.
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In comparison to existing methods for the analysis of dermal absorption of compounds, 
MALDI-MS imaging is clearly an attractive alternative. The direct analysis of such 
samples however, has proven difficult. Skin is an exemplary case in which matrix 
crystalisation on the tissue surface is found to be problematic. Even after extensive 
washing in several gradients of ethanol, matrix crystalisation on the tissue surface is 
poor and ion signals from the sample surface are weak. An indirect tissue imaging 
approach has been shown to be beneficial in analysing the distribution of xenobiotic 
compounds in skin cross-sections by MALDI-MS imaging.11
In the work described here, a tissue blotting approach incorporating an extraction 
solvent was used to provide a molecular imprint of the skin tissue on to a cellulose 
membrane support. The benefits of this approach are two-fold. By producing a 
molecular imprint of the tissue, not only are any problems associated with matrix 
crystalisation avoided, but the analytes are in effect selectively extracted from the tissue, 
thus reducing the complexity of the sample prior to image analysis.
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It has been found through preliminary experiments however, that this approach is not 
directly transferable to the analysis of all compounds. In the approach described by 
Bunch and co-workers, an imprint of the tissue was made onto a cellulose membrane 
that had been pre-coated in matrix. It may be assumed that when using this method that 
the transfer o f compounds from the skin to the membrane and the subsequent analyte- 
matrix co-crystalisation relies upon moisture within the tissue. It is therefore unlikely 
that compounds which present low water solubility will be transferred to the membrane 
or indeed co-crystalised with the matrix on the membrane surface. Theoretically, if the 
transfer of compounds from the tissue surface to a membrane is reliant upon solubility, 
introduction of a solvent to assist transfer should increase transfer efficiency 
accordingly. This approach was first described by Mullen et al. for the indirect imaging 
of agrochemicals in soya plants.12
In testing this hypothesis for the analysis of compounds in skin, the choice of analyte 
was extremely important. The compound must exist as a topically applied skin 
therapeutic, designed to be absorbed through the skin, and it must also be relatively 
water insoluble. For this experiment hydrocortisone has been found to be a suitable 
model compound (figure 3.1). Initial experiments show that this compound is not 
transferred to a cellulose membrane in the absence of a solvent to assist the blotting 
process.
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Figure 3.1 The Chemical Structure of Hydrocortisone
The chemical structure of hydrocortisone [11,17,21 -trihydroxy-, (llbeta)-
pregn-4-ene-3,20-dione] is shown.
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The corticosteroid hydrocortisone is used as an anti-inflammatory measure in the 
treatment of eczema and dermatitis. Upon topical application, hydrocortisone diffuses 
through the skin by both transfollicular and transepidermal routes.13 This compound 
also presents low water solubility (0.28 mg/mL), ensuring that the transfer of the analyte 
from the skin to a membrane surface is unlikely to be affected by residual water in the 
tissue itself. Furthermore, hydrocortisone presents high ethanol solubility, meaning that 
the analysis of this compound directly from the skin surface cannot be carried out. In 
preliminary experiments the vigorous ethanol washing steps required to achieve even 
the weakest ion signals from the skin surface were found to remove all traces of 
hydrocortisone from the skin tissue.
A number of experiments have been carried out to assess the solvent assisted blotting 
approach using the analysis of hydrocortisone from skin tissue as a model system. 
Arguments against the use of indirect imaging approaches relate primarily to a lack of 
abundance of the analyte as well as the loss of the original spatial orientation of analytes 
during the blotting process. The following experiments therefore aim to provide a 
method of optimizing the transfer of analyte to the membrane as well as to investigate 
the derogatory effects that introduction of a sample wetting step may have on the spatial 
integrity of the original sample.
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3.2 Materials and Methods
3.2.1 Materials
A generic hydrocortisone cream (0.1% w/w, active ingredient) was used in all skin 
treatment experiments. Porcine ear skin, obtained from a local abattoir was used as a 
model of human skin for the investigation.14 All other reagents were obtained from 
Sigma-Aldrich (Poole, Dorset, UK).
3.2 .2  M ethods
3 .2 .2 .1 A ssessm ent o f  Transfer Efficiency
Porcine skin tissue was treated with 2 mL of a commercial hydrocortisone cream (0.1% 
w/w active ingredient) over a 2 cm2 area. The sample was then incubated at 37°C for 1 
hour. After the incubation period, the excess hydrocortisone formulation was washed 
away. Cellulose membranes (2 cm2) were either applied in the absence o f solvent, or as 
saturated in the various solvents (methanol, ethanol or isopropanol). Where solvents 
were applied to membranes prior to blotting, the excess solvent was first blotted on to a 
clean piece of cellulose membrane and membranes were then left to air dry for 60 
seconds prior to blotting.
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Membranes were manually applied to the treated areas of the skin tissue surface under a 
pressure o f approximately 1 kg/cm2 for a period of 60 seconds. Hydrocortisone was 
extracted from the membranes in 1 mL of mobile phase (acetonitrile:water, 70:30) in 
preparation for subsequent quantitative HPLC analysis. The extraction efficiency of the 
mobile phase in removing hydrocortisone from the membrane was determined as >99%.
High performance liquid chromatography (HPLC) was used to validate the transfer 
efficiency of hydrocortisone from the skin to the membrane. Reversed phase HPLC has 
been used in these experiments as hydrocortisone is a relatively non-polar compound. 
The HPLC analysis was carried out using a Spherisorb ODS 15 pm column (25cm x 4.6 
mm) at a flow rate of 1 mL/minute using a mobile phase composed of acetonitrile:water 
(70:30). Detection of hydrocortisone was carried out by UV at a wavelength of 242 nm. 
All experiments were carried out in triplicate.
3 2 .2 .2  M atrix  O ptim isation
All analysis of hydrocortisone samples was carried out in positive ion mode. Several 
matrices were evaluated for the detection of hydrocortisone by spotting a 50:50 mixture 
of matrix (25 mg/mL in ethanol, 0.1% TFA):hydrocortisone (1 mg/mL in ethanol).
Matrices found suitable for detection of hydrocortisone were also tested for their ability 
to allow analysis of hydrocortisone from a cellulose membrane. Here, cellulose 
membranes were spiked with 1 pL volumes of hydrocortisone (1 mg/mL) and spray 
coated in matrix (25 mg/mL in ethanol, 0.1% TFA).
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Further experiments to ensure that matrices were suitable for the detection of 
hydrocortisone in the presence of other compounds that may be transferred from the 
skin during the blotting process were also carried out. In these experiments, ethanol 
assisted cellulose membrane blots of skin treated with hydrocortisone formulation 
(0.1% w/w) were spray coated in matrix (25 mg/mL in ethanol, 0.1% TFA). For each 
of the experiments described, an experimental blank was also prepared in the same way 
in the absence o f hydrocortisone.
3 .2 .2 .3 A ssessm ent o f  L ateral Diffusion
In optimising the extent of lateral diffusion of analytes during the blotting process 
experiments were carried out to assess the effects of the extent of solvent saturation of 
the membrane as well as the period of time over which membrane extraction (blotting) 
took place. This was achieved by treating porcine skin tissue with commercial 
hydrocortisone cream (0.1% w/w active ingredient) over a defined region using an in- 
house device which confined the treatment region to a circular area, 6 mm in diameter. 
The treated tissue was incubated for 1 hour at 37°C. The excess formulation was then 
washed away from the surface using a 5 second water rinse. Ethanol saturated cellulose 
membranes were then left to air dry for 30, 60 and 90 seconds prior to blotting.
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Each degree of membrane saturation was assessed in conjunction with 30, 60 and 90 
second membrane extraction periods. The resulting membrane blots were coated by air- 
spray from a distance of 10 cm with approximately 5 mL of matrix solution (25 mg/mL 
a-CHCA in acetone, 0.1% TFA). Acetone was used as a matrix delivery solvent in 
these experiments to ensure minimal lateral analyte diffusion was induced during the 
matrix application process. Images were acquired at 200 pm resolution, with a laser 
dwell time of approximately 2 seconds at each position. Measurements of 
hydrocortisone distribution in each sample were made using the metric scale of the 
imaging software.
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3.3 Results
3.3.1 A ssessm ent o f  Transfer E fficiency
Figure 3.2 shows how the HPLC results of the solvent assisted transfer efficiency tests 
relate to the solubility o f hydrocortisone in each of the solvents assessed. As can be 
seen from this graph, the extraction efficiencies observed follow the predicted trend, 
correlating with the solubility of hydrocortisone in each of the solvents.
The highest transfer efficiency obtained was through use of an ethanol soaked 
membrane to assist the blotting process. Using ethanol as the blotting solvent provided 
more than 80-fold increase in transfer efficiency when compared to relying on residual 
moisture within the tissue. These results indicate that the solvent assisted blotting 
approach can be used to increase transfer efficiency and limits of detection considerably.
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Figure 3.2 Transfer Efficiency and Solubility of Hydrocortisone
Hydrocortisone transfer efficiency increases in accordance with compound solubility in 
each of the transfer solvents. Ethanol was found to give the highest level of transfer of 
hydrocortisone to the membrane. It is thought that the level of hydrocortisone 
transferred to the membrane using isopropanol was reduced due to the viscosity of the 
solvent.
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3.3.2 Matrix Optimisation
The most suitable matrix found for use in imaging of hydrocortisone from membranes 
was a-CHCA. Examples of detection of hydrocortisone using this matrix on spot 
targets, from spiked cellulose membranes and from hydrocortisone treated skin tissue 
blots are shown in figures 3.3 to 3.5. This matrix not only provided the best ion signals 
of hydrocortisone in each of the examples shown, but is also found to be an ideal matrix 
for image analysis due to the small matrix crystal size and homogeneity of crystal 
formation on the membrane surface.9
In figure 3.3 we can see in the blank a-CHCA spectrum that matrix peaks exist at m/z 
363.09 and 363.33. The hydrocortisone molecular ion [M+H]+ has a mass of 363.22, 
meaning that a mass resolution of more than 3500 is required to resolve the peaks. The 
mass resolution of the QStar Pulsar i instrument is in the region of 10,000 and is 
therefore adequate to resolve these ions and to allow subsequent image analysis. 
Further examination also revealed that there is no signal interference from either the 
cellulose membrane (figure 3.4) or the membrane blot (figure 3.5), as hydrocortisone 
was readily detected in all samples.
86
Chapter 3
a-CH CA  B la n k
1.2*4-  
c  1.0*4-  
g  8000.0  
£  6000.0
4000.0 ■
358.0881 ,
-  J L a . s I?3319?:- 384.0931 385.1074
351.0 352.0 353.0 354.0 355.0 356.0 388.0 369 0
H y d io c o i t is o n e
2.2e4
2 .0e4
1.8*4
1.6*4
1.4*4
°  1 .2e4£
c  1.0e4  
— 8000.0  
6000.0
4000.0
2000.0 
0.0^
[M+HJ+I
363.2184
357.0896 358.Q8Q3 360 .3 4 5 8 -^  3 61 .0856 36 2 2 1 4 0  33; . 3525
351.0 352.0 353.0 354.0 355.0 356.0 357.0 359.0 380.0 361.0 362.0 383.0 384.0 365.0 368.0 367.0
Figure 3.3 Detection of Hydrocortisone on Spot Targets
MALDI-MS spectrum obtained from a spot target sample of 1:1 hydrocortisone 
(lm g/mL): a-CHCA (25 mg/mL) compared against a MALDI-MS spectrum of an a- 
CHCA blank.
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Figure 3.4 Detection of Hydrocortisone on Cellulose Membranes
MALDI-MS spectrum of a cellulose membrane spiked with lp L  hydrocortisone 
(lm g/m L) and spray coated with a-CHCA (25 mg/mL) compared against a MALDI-MS 
spectrum of a cellulose membrane coated in the same way with a-CHCA as a blank.
Chapter 3
O u ts id e  h y d ro c o r tis o n e  t r e a tm e n t  re g io n
353.1223
.. j L . 360 1407 ,.Ai.il, X 364.1620 ,.A-, 368 .0956 369 .1151 jItol_L351.0 352.0 353.0 354.0 355.0 356.0 357.0 358.0 369.0 360.0 361.0 362.0 363.0 364.0 365.0 386.0 387.0 368.0 369.0 370.0
In s id e  d u n j  T rea tm en t ie<jion [M+HJ+
363.2838
362.1297 303.1
- ,L  J
351.0 352.0 353.0 354.0 355.0 356.0 357.0 358.0 359.0 360.0 361.0 362.0 363.0 364.0 365.0 366.0 367.0 368.0 369.0 370.0
Figure 3.5 Detection of Hydrocortisone on Cellulose M embrane Blots
MALDI-MS spectra taken from an ethanol assisted cellulose membrane blot of skin 
tissue treated with hydrocortisone formulation (1% w/w) and spray coated in a-CHCA 
(25mg/mL). Spectra from inside and outside the drug treatment area are shown. The 
protonated molecule of hydrocortisone is observed at m/z 363.29.
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3.3.3 Assessment o f Lateral Diffusion
Figure 3.6 shows the data obtained from experiments conducted to assess the lateral 
diffusion of analyte during the blotting process. It was found that the major factors 
associated with extended lateral diffusion were the amount of solvent present on the 
membrane during the blotting process and the length of time over which blotting took 
place.
With shorter drying times of 30 seconds, high ion signals for hydrocortisone are 
obtained. This is combined, however, with an extensive degree of analyte spreading.
As the drying time is increased, hydrocortisone ion signals are reduced, but a general 
reduction in the extent of lateral analyte diffusion is observed. Samples prepared with 
60 and 90 second drying times show a positive trend in the amount o f hydrocortisone 
transferred to the membrane as the transfer time is increased. Whilst samples prepared 
after allowing the membrane to dry for 90 seconds present the least amount of analyte 
spreading, these samples show less uptake of the analyte than is observed with samples 
prepared after 60 seconds membrane drying time. Based on these results, it would 
appear that a membrane drying time of 60 seconds combined with a transfer time of 90 
seconds provides the optimum conditions to ensure a good level of sensitivity whilst 
ensuring analyte spreading is kept to within an acceptable limit.
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Figure 3.6 Hydrocortisone Lateral Diffusion Images
The images shown are representative of the degree of analyte diffusion using various 
drying (i.e. wetness of the cellulose membrane) and blotting times in mapping the 
distribution of hydrocortisone from porcine skin treated over a 6mm diameter region 
with a 0.1% hydrocortisone formulation. The ion intensity range was adapted 
individually to each image to best represent the degree of lateral diffusion. As such, 
comparison between apparent abundance of analyte should be disregarded.
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3.4 Conclusion
The solvent assisted blotting approach is useful in allowing MALDI-MS imaging of 
compounds from tissues not amenable to direct analysis. It has been shown that 
attention to analyte properties is extremely important in optimising an indirect imaging 
approach. In this experiment, compound solubility was found to be an important factor. 
In using an appropriate solvent to assist blotting, a high level of sensitivity for the 
compound was obtained.
Clearly, incorporation of a wetting step during the sample preparation process does lead 
to some analyte spreading. It has been shown however that with proper optimisation, 
lateral migration can be limited to approximately 10%. Whilst this may limit 
applications, it is thought that for the purpose of some investigations this degree of 
spreading may not be significant.
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MALDI-MS Imaging for 
Pre-clinical Applications
Chapter 4
4 MALDI-MS Imaging for Pre-clinical Applications
4.1 Introduction
Observing the activity and metabolism of drugs inside the body is an important step in 
drug development. The potential of MALDI-MS imaging for studying drug 
distributions is of great interest to the pharmaceutical industry. Researchers hope that 
this technique may complement existing technologies by allowing simultaneous 
mapping of and distinction between structurally related drug metabolites; a limitation of 
existing drug imaging approaches.
Conventionally, drug distribution studies have been reliant upon autoradiographic and
immunofluoresence imaging. Whilst these methods enable tracking of the drug
compound they are not necessarily able to trace the drug metabolites. Mass
spectrometry based techniques have become the industry standard for looking at drug
distributions. LC-MS analysis may be used to provide some resolution to the specificity 
1 ^issue ‘ , however crude sampling methods (involving extraction of target compounds 
from tissue homogenates) do not allow determination of heterogeneous distribution 
within a tissue. It is with this objective in mind that MALDI-MS imaging is being 
evaluated for its potential to bridge the gap between autoradiographic imaging and LC- 
MS analysis.4,5
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With the latest prodrug technologies, it is required that imaging techniques are capable 
of distinguishing between compounds where structures are defined by as little as one 
atom. Moreover, with therapeutic strategies being directed toward reduced dosing in 
patients, the analysis must have sufficient sensitivity to detect these compounds at low  
abundance. For MALDI-MS imaging to successfully achieve this goal, measures must 
be taken to ensure that compound specificity is maintained and that drug signals are not 
impaired.
Unlike LC-MS analysis, where extraction of analytes from tissues and chromatographic 
separation reduces the complexity of samples prior to ionisation, desorption and 
ionisation in MALDI-MS image analysis is carried out directly from the tissue surface. 
In our own studies it has been found that fragmentation during the ionisation process 
can interfere with compound specificity. Structures of the fragment ions of a drug may 
mimic the molecular ions of drug metabolites, leading to production of ‘false’ images. 
This is difficult to resolve, even with MS-MS imaging capabilities.
Furthermore, due to the high level of sample complexity, ion suppression in MALDI- 
MS imaging is common. Ion suppression may lead to an apparent reduced abundance 
or complete loss in detection of the compound(s) of interest, either in confined regions 
of the image or throughout the entirety of the image run. Similarly, with ionisation in 
MALDI-MS being reliant upon the presence of a matrix, variability in matrix coverage 
can be seen to add to this effect. Again, either one or both of these factors may lead to 
the production of ‘false’ images.
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In the following experiments potential methods to overcome these problems using 
experimental controls and by optimising sample preparation methods are demonstrated. 
In this study MALDI-MS imaging is investigated for its ability to image the distribution 
of a prodrug and its active metabolite. The compound chosen for this analysis is a novel 
anticancer drug which is currently in the early stages of phase II clinical trials.
A large proportion of human cancers present as solid tumours.6 Effective treatment of 
solid tumours is limited by the presence of hypoxic regions within tumour tissue. 
Hypoxia is a rare physiological occurrence associated with cases of severe oxygen 
depletion such as stroke, arthritis and cardiac arrhythmias. In tumours, hypoxia occurs 
through combination of the high oxygen demand of dividing cells and irregularities in 
tissue vasculature. Perfusion deficits as well as the metabolic changes that occur in 
hypoxia render hypoxic cells resistant to conventional cancer therapies. If left untreated 
these cells have the potential become reoxygenated, leading to increased likelihood of 
tumour regrowth.7
Much research has been directed toward harnessing the reductive conditions that persist 
during a hypoxic episode in order to facilitate treatment of solid tumours. Bioreductive 
drugs available include N-oxides such as tirapazamine, aziridinylnitroimidazoles RSU  
1069/RBU 6145 and quinones such as indoloquinone E09A Q 4N.8
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AQ4N (1,4-bis- {[2-(dimethylamino-A-oxide)ethyl]amino} 5,8-dihydroxyanthracene-
9,10-dione) is a member of the N-oxide functionality group of bioreductive anticancer 
agents.9, 10 This novel compound, devised to circumvent the therapeutic resistance 
induced by hypoxia, has been shown to significantly enhance radiation therapy as well 
as improving the anti-tumour effects of drugs such as cyclophosphamide and 
cisplatin.11,12
The activation of AQ4N is shown to be largely confined to within tumours. Studies 
have found that only a low proportion of AQ4N administered to the body is 
systematically metabolised to the active metabolite AQ4 (<2% of the AQ4N for all 
doses administered). This low systemic release of the cytotoxic metabolite reduces side 
effects and allows dosing in patients up to 200 mg/Kg.
Under reduced oxygen conditions and facilitated by bioreductive enzymes, AQ4N  
undergoes metabolic N-oxide reduction to produce the cytotoxic compound AQ4 
(figure 4.1). AQ4 is a DNA affinic which inhibits Topoisomerase II activity, an enzyme 
which is critical to cellular DNA processing. AQ4 inhibition of this enzyme functions 
to sychronise cell growth, sensitising cells to fractionated radiotherapy and some forms 
of chemotherapy. Whilst there are a number of bioreductive drugs available with 
similar pathophysiological effects, AQ4N has the exclusive capacity to retain activity
ft 1 ^upon tissue reoxygenation. ’
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AQ4N is an ideal candidate for assessing the potential of MALDI-MS imaging in pre- 
clinical assessment. As well as being a highly selective compound, the prodrug also 
presents a high level of structural homology with the active metabolite. The overall aim 
of this experiment is to validate that the site of bioreductive activation of AQ4N 
correlates with regions of hypoxia within tumours. This is to be carried out by mapping 
the distributions of AQ4N and AQ4 in human tumour xenographs, excised from mice 
previously treated with AQ4N. The following experiments describe the steps taken 
towards optimising sample preparation for the detection of AQ4N and AQ4 in treated 
tumour samples.
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Figure 4.1 Chemical structures of AQ4N and its major metabolites.
Bioreduction of the prodrug AQ4N produces the intermediate metabolite AQ4M. 
AQ4M is further reduced to form the active compound AQ4. These reactions occur in 
the highly reductive environment that exists in hypoxia.
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4.2 Materials and Methods
In determining the distribution of AQ4N and AQ4 in tumour tissue, it is required that 
these compounds can be detected simultaneously. Optimisation of matrices and other 
experimental parameters have been carried out to ensure a high level of sensitivity and 
selectivity is achieved throughout the analysis.
4.2.1 Materials
AQ4N and AQ4 standards were synthesised as previously described.14 These 
compounds and the H460 human tumour xenographts were obtained from the Institute 
of Cancer Therapeutics, University of Bradford, Bradford, UK. Treated H460 human 
tumour xenographts were taken from tumour bearing mice after 24 hours treatment with 
AQ4N (lOOmg/Kg, intraperitonally (i.p.)). Tumours were flash frozen immediately 
upon excision and stored at -80°C. All animal experiments were carried out under a 
project licence approved by the UK Home Office, London, UK. Untreated H460 human 
tumour xenographts were obtained and stored under the same conditions.
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All tumour cryosections were produced using a Leica cryostat (Leica Microsystems, 
Wetzlar, Germany). Sections were produced at 12 pM thickness in the absence of 
embedding medium at an operating temperature of -20°C. The sections were placed 
directly onto disposable aluminium sheets in preparation for MALDI matrix application. 
All tissue sections used in MALDI-MS image analysis were prepared and run on the 
same day to avoid sample degradation. All other reagents were obtained from Sigma- 
Aldrich (Poole, UK).
4 .2 .2  M ethods
4 .2 .2 .1 M atrix O ptim isation
A range of matrices were tested as potential candidates for MALDI-MS image analysis 
of AQ4N and AQ4. All matrices were made up to a final concentration of 25 mg/mL in 
ethanol, 0.1% trifluoroacetic acid (TFA). AQ4N and AQ4 standards (1 mg/mL) were 
mixed 50:50 with each of the matrices and spotted onto a stainless steel MALDI target 
in 1 pL volumes. MALDI-MS spot samples were run manually at a 30% laser power 
(3.2 pJ).
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4.2 .2 .2  D etection  o f  Com pounds from  Tumour Tissue
Experiments have been carried out to ensure detection of compounds directly from the 
tissue surface. Both a-CHCA and DHB matrices were tested for suitability for the 
detection of AQ4N and AQ4 in tumours. Untreated tumour sections were spotted with 
lpL  volumes of AQ4N and AQ4 at 1.0, 0.1 and O.Olmg/mL concentrations. Samples 
were then coated with approximately 5mL of matrix (25mg/mL in ethanol, 0.1% TFA) 
by air-spray deposition and MALDI-MS analysis was carried out manually on the drug 
spike regions using a laser repetition rate o f lKHz and a laser power of 30% (3.2p J).
4.2 .2 .3  A ssessing the Effects o f  DNA Binding on A Q 4 Ionisation
The DNA binding properties of AQ4 may significantly reduce ionisation of this 
compound from the tissue surface. An experiment was carried out to assess how 
ionisation of AQ4 was affected in the presence of DNA and how alteration of  
experimental pH may function to dissociate AQ4 and enhance ion signals. All samples 
were prepared in triplicate using stock solutions of AQ4 (lmg/mL) and DNA (5pg/mL). 
a-CHCA matrix solutions (25mg/mL in ethanol) were used at varying TFA 
concentrations (0-2.0%) to investigate the effect of pH on AQ4/DNA dissociation. 
Table 1 illustrates the composition of the samples in more detail.
104
Chapter 4
4.2.2.4 Imaging o f AQ4N and AQ4 in Tumours
Test image samples were prepared to evaluate the benefits of altering matrix TFA 
concentration on detection of AQ4N and AQ4 from tumour tissue. Untreated H460 
human tumour xenograph tissue sections were spiked with lpL  volumes of AQ4N  
(1 mg/mL) and AQ4 (1 mg/mL) and spray coated in matrix with the various TFA 
concentrations (0.1%, 1.0% and 2.0%).
Imaging of treated H460 human tumour xenograph tissue sections was carried out to 
determine the distribution of both AQ4N and AQ4 through out the tumour tissue. These 
experiments were carried out in the presence of experimental controls to ensure 
selectivity between AQ4N and AQ4.
All images were run at 200pm resolution with a laser power of 30% using a beta test 
version of the Applied Biosystems/MDS Sciex ‘Dynamic Pixel’ imaging mode. In this 
mode, rather than performing stationary laser irradiation at each image voxel position, 
the sample is moved beneath the laser within the confinements of the user-defined voxel 
dimensions. This aims to address sensitivity issues associated with the use of an 
Nd:YAG laser with a Gaussian beam profile.15
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Standard Solutions AQ4 (1 mg/mL) DNA (5gg/mL) a-CHCA (25mg/mL) h 2o
AQ4+ a-CHCA lgL - 5gL 4gL
AQ4+ DNA+a-CHCA IgL 4gL 5gL -
AQ4+ DNA+a-CHCA (0.1% TFA) lgL 4gL 5jaL (0.1% TFA) -
AQ4+ DNA+a-CHCA (1.0% TFA) lgL 4pL 5jjL (1.0% TFA) -
AQ4+ DNA+a-CHCA (2.0% TFA) IgL 4gL 5gL (2.0% TFA) -
Table 1 Sample Composition for DNA/AQ4 Binding Experiments
The table illustrates the composition of samples prepared for MALDI-MS analysis in 
the determination of the effects of pH on DNA/AQ4 binding.
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4.3 Results
4.3.1 Matrix Optimisation
A total of five matrices were evaluated as potential candidates for MALDI-MS image 
analysis of AQ4N and AQ4. The results of this experiment are shown in figure 4.2, 
where detection of each of the drug compounds is illustrated as a percentage o f the base 
peak of each spectrum.
AQ4N was detected as both the protonated molecule [M+H]+ at m/z 445 and as the 
sodium adduct [M+Na]+ at m/z 467 using all matrices, with the exception of 
hydroxypicolinic acid (HPA). Similarly, AQ4 was detected as the protonated molecule 
[M+H]+ at m/z 413 using all matrices with the exception of sinapic acid (SA).
As it is required for imaging that both compounds are detected simultaneously, both 
sinapinic acid and hydroxypicolinic acid are unsuitable matrices for this analysis. 
Whilst 2-(4-hydroxyphenylazo) benzoic acid (HABA) is shown to provide a reasonable 
level of sensitivity in the detection of the sodium adduct of AQ4N, this matrix was 
disregarded due to the poor ion signals observed for AQ4.
Based on these results, dihydrobenzoic acid (DHB) and a-cyano,4-hydroxy cinammic 
acid (CHCA) were selected for subsequent testing for the detection of AQ4N and AQ4 
in tumour sections. Both compounds were readily detected using these matrices. 
Spectra obtained using a-CHCA and DHB matrices for each of the compounds are 
shown in figures 4.3 and 4.4 alongside matrix blanks.
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Figure 4.2 Evaluation of Matrices for Analysis of AQ4N and AQ4
Ion intensities of analytes are presented as the percentage of the base peak within each 
spectrum to allow comparison between spectra of varying ion intensity scale. From 
these results a-CHCA and DHB are found to be the most suitable matrices as these 
allow detection of both AQ4N and AQ4.
108
Chapter 4
M atrix B lan k
2833 -JW1C 
50% - 
40%
30% - 
20% -0928
10%
AQ4N
A 04N  [M+HJ+ A 04N  |M »N a]+
40% - 
30% ■ 
2 0 % - 
10% - 412.2232 417.0818 <fr2p.Q962
A A / i  I  i  .
400 405 410 415 420 425 430 435 443 446 450 455 460 465 470 475 485 490 495 500
AQ4
100%
80%
60%
40%
20%
0%
411.215* 
4 Cc.0918 410 .2"Bf f h . , . . - i l l .
417.0571 421.0767
h j lJ .A  4
405 410 415 420 425 430 435 440 445 450 455 460 465 470 475 485 490 495 500
Figure 4.3 AQ4N and AQ4 Detection with a-CHCA Matrix
The protonated molecule [M+H]+ of AQ4 and the protonated molecule and sodium 
adduct of AQ4N are detected using a-CHCA matrix. Whilst a-CHCA matrix presents 
peaks with masses closely matching those of AQ4 [M+H]+ and AQ4N [M+H]+, the 
instrument has sufficient mass resolution to define analyte peaks from the matrix.
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Figure 4.4 AQ4N and AQ4 Detection with DHB Matrix
The protonated molecule [M+H]+ of AQ4 and the protonated molecule and sodium 
adduct of AQ4N are detected using DHB matrix. Whilst DHB matrix produces ions 
with mass to charge ratios closely matching those of AQ4 [M+H]+ and AQ4N [M+H]+, 
the mass resolution required to resolve these peaks (e.g m/z 413.2338 from m/z 
412.2279) is less than 400. Operationally, the Q-Star typically achieves 10,000 mass 
resolution (FWHM definition), therefore it is sufficient to define analyte peaks from the 
matrix.
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4.3.2 Detection o f Compounds Directly from Tumour Tissue
In assessing DHB and a-CHCA for direct tissue analysis of AQ4N and AQ4, it was 
found that DHB was not a suitable matrix. Intensities of DHB matrix peaks were low  
and neither analyte could be detected from the tissue surface.
Success in detection of both AQ4N and AQ4 from the drug spiked tissue regions was 
achieved using a-CHCA, although ion signals were quite weak. Spectra taken from 
each of the drug spike regions are shown in figures 4.5 and 4.6 alongside spectra taken 
from blank areas of the tumour tissue.
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Figure 4.5 AQ4N Detection on Tumour Tissue Using a-CHCA
AQ4N [M+Na]+ was detected from an AQ4N drug spike region of tumour tissue at m/z 
467.17. High ion signals were obtained for AQ4N [M+Na]+ but AQ4N [M+H]+ could 
not be detected.
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Figure 4.6 AQ4 Detection on Tumour Tissue Using a-CHCA
AQ4 [M+H]+ was detected from an AQ4 drug spike region of tumour tissue at m/z 
413.26. Whilst the ion peak was well distinguished from neighbouring ion peaks, the 
signal response for the AQ4 [M+H]+ ion was weak.
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4.3.3 Assessing the Effects o f DNA Binding on AQ4 Ionisation
As a result of initial failed experiments in the detection of AQ4 directly from tumour 
tissue at concentrations <0.1 mg/mL, the effects of DNA binding properties on 
detection of AQ4 were investigated. Assessment of the effects of pH in allowing 
dissociation of AQ4 from DNA were also carried out.
The results of the DNA binding and evaluation of experimental pH on AQ4 ion signals 
are illustrated in figure 4.7. Here, average ion intensities of the AQ4 [M+H]+ 
normalised against a-CHCA [M+H]+ indicate that although AQ4 ion signals are 
impaired in the presence of DNA, this effect may be reversed by increasing the amount 
of TFA added to the matrix.
In the absence of DNA AQ4 is readily detected as the protonated molecule at m/z 413, 
yet when DNA is present AQ4 ion signals are drastically reduced. Figure 4.8 shows the 
average ion intensities for both AQ4 [M+H]+ and a-CHCA [M+H]+. From these data it 
can be seen that although an increase in matrix TFA concentration elevates matrix ion 
signals, the change in AQ4 ion intensity is unrelated. This would indicate that the 
DNA-affinic properties of AQ4 were responsible for the poor sensitivity observed in the 
initial direct tissue experiments.
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AQ4 & DNA pH Test
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Figure 4.7 The effects of DNA and pH on AQ4 Detection
The AQ4 peak areas of the protonated molecule of AQ4 (m/z 413) normalised against 
the protonated molecule of a-CHCA (m/z 190) are shown in the presence and absence 
of DNA at various TFA concentrations (0-2.0%). The presence of DNA is shown to 
significantly reduce AQ4 ion signals, but the addition of TFA to the matrix appears to 
dissociate the AQ4 from the DNA allowing the compound to be detected. This is seen 
here as an elevation of AQ4 ion signals normalised against the matrix increase in 
accordance with matrix TFA concentration.
115
Chapter 4
45 i
40
35
£  30 -! </) c<D
I  25 jco
© 20 O)
0)>< 15
10
AQ4 + Matrix AQ4 + DNA + CHCA AQ4 + DNA + CHCA 
(0.1% TFA)
AQ4 + DNA + CHCA 
(1.0% TFA)
AQ4 + DNA + CHCA 
(2.0% TFA)
□ AQ4 [M+H]+ □ CHCA [M+H]+
Figure 4.8 The Effects of TFA on AQ4 and a-CHCA Ion Signals
The graph shown illustrates the changes in signal responses for the protonated molecule 
of AQ4 (m/z 413) and the protonated molecule of a-CHCA (m/z 190) in the absence of 
DNA and TFA. Small changes in a-CHCA ion signal as the matrix TFA concentration 
increases may indicate that the TFA enhances ionisation of this compound. Much 
larger changes in AQ4 ion signals are observed as the matrix TFA concentration 
increases. This would indicate that increase in AQ4 ion signals is not dependant upon 
the matrix, but is dependant up pH.
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4.3.4 MALDI-MS Imaging o f AQ4N and AQ4 in Tumours
Further investigation into the effects of varying matrix TFA concentration on analyte 
detection has been carried out by MALDI-MS imaging. Comparison of 0.1, and 2.0% 
matrix TFA concentrations on image quality has been assessed using drug spiked 
untreated tumour samples (figures 4.9 and 4.10 respectively).
In experiments where a matrix TFA concentration of 0.1% TFA was used AQ4N  
[M+Na]+ was detected with high sensitivity from the tumour surface. In these 
experiments, however, AQ4 could not be detected at all.
In experiments where a matrix concentration of 2% TFA was used AQ4 [M+H]+ was 
detected with high sensitivity, yet the AQ4N [M+Na]+ signal was noticeably reduced.
It is apparent from these results that whilst a matrix TFA concentration of 2% is found 
to increase sensitivity for the detection of AQ4, with this level of TFA present AQ4N  
signals seem to be suppressed. In order to assess the effects of matrix pH on DNA/AQ4 
binding (presented in section 4.3.3 of this chapter) further imaging experiments have 
been carried out using a matrix TFA concentration of 1%. In the AQ4/DNA binding 
experiments it was found that whilst a matrix TFA concentration of 2% provided the 
highest ion signals for AQ4, a matrix concentration of 1% also provided a significant 
increase in sensitivity for AQ4. In order to assess the effects of high TFA concentration 
on the detection of AQ4N, a 1% TFA concentration is thought to be a reasonable 
compromise in allowing simultaneous detection of both compounds.
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Figure 4.9 MALDI-MS images of Drug Spiked Tissue 0.1% TFA
An image of the potassium adduct of the phosphatidylcholine head groups at m/z 222 is 
shown in black and white (a). This ion is suppressed in the regions of the tissue that 
have been spiked with the drug compounds (AQ4 and AQ4N), this clearly illustrates the 
drug spike regions. The distribution of AQ4N [M+Na]+, shown here as a colour overlay 
(b) is confined to the AQ4N drug spike region. AQ4 was not detected in this analysis. 
The AQ4N ion image was normalised against the respective ion species of the matrix
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Figure 4.10 MALDI-MS images of Drug Spiked Tissue with 2% TFA
An image of the potassium adduct of the phosphatidylcholine head groups at m/z 222 is 
shown in black and white (a). This ion is suppressed in the regions of the tissue that 
have been spiked with AQ4. In contrast to images obtained using 0.1% TFA the m/z 
222 ion is not suppressed in the AQ4N drug spike region. The distribution of AQ4N 
[M+Na]+ at m/z 467, shown here as a colour overlay, is confined to the AQ4N drug 
spike region (b). This image shows a marked decrease in sensitivity for AQ4N when 
using matrix with 2% TFA compared to using matrix with 1% TFA. The distribution of 
AQ4 [M+H]+ at m/z 413, also shown as a colour overlay is confined to the AQ4 drug 
spike region (b) and presents a high level of sensitivity using this matrix TFA 
concentration. Both AQ4N and AQ4 ion images were normalised against the respective 
ion species of the matrix.
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Figure 4.11 shows the ion images obtained for AQ4 and AQ4N from an AQ4N treated 
tumour tissue section alongside an image of the distribution of the phosphatidylcholine 
head group at m/z 184. The images include controls for each o f the drug compounds to 
ensure that specificity between drug and metabolite has been maintained. In these 
images it appears that whilst both AQ4N and AQ4 are detected throughout the tissue, 
the distributions for each compound are significantly different.
The bicolour image shown in section 4.3.5 (figure 4.13) illustrates the difference in 
distribution of the compounds within the tissue. Here it can be seen that these 
compounds co-exist in very few locations throughout the tissue. Interpretation of this 
image, based on the known activation mechanism of AQ4N, would infer that AQ4N  
may exist in the oxygenated regions of the tissue and that AQ4 may exist in the hypoxic 
regions of the tissue. This theory is further evaluated in the next section of results.
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Figure 4.11 Distribution of AQ4N and AQ4 in Treated Tumour Tissue
An image of the distribution of the phosphatidylcholine head group [M+H]+ (m/z 184) is 
shown to illustrate the position of the tumour section within the image (a). Ion images 
of AQ4 [M+H]+ at m/z 413 (b) and AQ4N [M+Na]+ at m/z 467 (c) are also displayed. 
All images have been normalised against the respective ion species of the matrix. A 
high level of specificity is observed for the detection of each compound, with the 
controls for AQ4 and AQ4N being clearly defined. There is a marked difference in the 
distribution of AQ4 in comparison to the distribution of AQ4N.
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4.3.5 U sing Endogenous Markers to D efine H ypoxic T issue R egions
The endogenous compound ATP has been used as a marker for hypoxia in this 
experiment. In the images obtained, ATP was readily detected as the fragment ion at 
m/z 409 (corresponding to the loss of H3PO4). In the images shown in figure 4.12 it can 
be seen that the distribution of ATP is highly correlated with the distribution of AQ4N  
shown in figure 4.11. As ATP depletion is one of the first effects observed in hypoxia, 
this may imply that AQ4N is largely confined to oxygenated regions of the tissue.
In contrast, AQ4 distribution is found to oppose ATP distribution (i.e. AQ4 is found at 
elevated levels where ATP is found at reduced levels within the tissue). This may 
imply that AQ4 is largely confined to hypoxic regions of the tissue. Figure 4.13 shows 
bicolour images of AQ4 and AQ4N as well as AQ4 and ATP. These images illustrate 
the contrast between AQ4 and AQ4N distribution as well as the contrast between AQ4 
and ATP distribution.
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ATP control
Figure 4.12 Image of the distribution of ATP in an AQ4N Treated Tumour
The image displayed is taken from a negative ion image acquisition of the AQ4N 
treated tumour sample. The distribution of ATP fragment ion at tri/z 409 reflects the 
distribution of AQ4N [M+Na]+ shown in figure 4.11 A high level of specificity is 
observed for the detection of ATP, with the control for this compound being clearly 
defined.
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Figure 4.13 Bicolour images of the distribution of AQ4, AQ4N and ATP
The bicolour image of AQ4 (red) and AQ4N (green) shows the contrast between AQ4 
and AQ4N distribution (a). The bicolour image of AQ4 (red) and ATP (blue) shows 
similar contrast in distribution (b). It can also be seen from these images that AQ4N 
(shown in image a) and ATP (shown in image b) present very similar distributions.
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4.4 Conclusion
MALDI-MS imaging has been successfully applied to the analysis of the prodrug 
AQ4N and its active metabolite AQ4 in AQ4N treated H460 human tumour xenographs. 
It has been found that AQ4N and AQ4 distributions complement the theoretical 
assumptions made on the distribution of these two compounds based on the 
understanding of hypoxia induced activation of AQ4N.
Regions o f hypoxia have been defined in these analyses by the reduced abundance of 
ATP in oxygen depleted regions. It appears from the results obtained that AQ4N 
distribution correlates with the detection of typical levels of ATP expected in normal 
oxygenated tissue. Contrasting images of AQ4 distribution suggest that elevated levels 
of AQ4 are largely confined to hypoxic regions (i.e. those where ATP abundance is 
reduced). This evidence further validates the highly selective nature of this drug.
The DNA binding properties of AQ4 have been shown to contribute to reduced 
sensitivity, and in some cases complete loss, in the detection of AQ4 both in the 
presence of DNA and directly from the tumour tissue surface.
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These experiments illustrate the importance of sample preparation in the application of 
MALDI-MS imaging for pre-clinical analysis and also indicate a necessity for 
collection of preliminary evidence of sample constituents. It is clear from this analysis 
that by underestimating the importance o f optimisation of sample preparation 
procedures, false conclusions may be made. In the absence of preliminary experiments 
(LC-MS of tissue homogenates, for example) to crudely determine the expected 
presence of analytes in a sample, it is possible that the existence of AQ4 in these treated 
tumour sections may have been overlooked.
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5 Pre-processing of MALDI-MS Image Data
5.1 Introduction
The information gathered in MALDI-MS imaging is highly complex by nature. There 
are many variables besides those intended for analysis that may cause difficulties in 
interpreting experimental results. These variables can to some extent be separated in to 
two different categories; sample induced variability and analytically induced variability.
5.1.1 A nalytically Induced Variability
Analytically induced variability relates primarily to the MALDI-MS process itself, 
where the complex nature of samples being analysed gives rise to spectrum-spectrum 
changes in levels of ion suppression. Ion suppression is thought to occur as a result of 
the differences in proton affinity between molecules, with a limited availability of 
protons providing a competitive environment for the ionisation process.
Whilst the pattern of suppression may be relatively constant in replicate samples or 
where analytes possess high proton affinity, in sampling chemically diverse material 
such as biological tissue (or where analytes present a particularly low proton affinity), 
suppression patterns may alter significantly from one spectrum to another. This may 
cause problems in assigning true relativity to analyte abundance, and in extreme cases 
can cause difficulties in interpretation of data.
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Problems relating to ion suppression can be reduced to some extent by optimising the 
sample preparation process. Optimisation can provide an increase in the sensitivity of 
analysis for a particular compound or group of compounds and may aid in reducing the 
prevalence of false negatives in extreme cases of analyte suppression. Optimisation 
does not, however, alleviate the issue of ion signal variance attributed to ion suppression.
With suppression effects occurring as a result of the competitive nature of the ionisation 
process, it is unlikely that this effect can be avoided. Moreover, with the subject of 
suppression being of such high complexity, it is difficult to contemplate its correction 
via post-acquisition data pre-processing.
5 .1 .2  S ample Induced Variability
Post-acquisition data pre-processing is largely concentrated on other aspects of 
experimental error which may be more susceptible to manual control. Other aspects 
considered relate largely to the sample itself as opposed to the analytical process. 
Several effects are described which may alone, or in combination, contribute to 
generation of experimental errors in image data. The first of these effects occurs due to 
adduct formation and may be more evident in small molecule analysis.
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5.1.3 Adduct Processes
During the MALDI process molecules may be ionised by proton addition or by 
cationization with alkali metal ions. The problem this raises in MALDI-MS imaging 
relates to the reproducibility of the adduct process between image spectra.1
Whilst the exact mechanism of the adduct process may remain elusive, its effects cannot 
be ignored when attempting to give a semi-quantitative representation o f analyte 
abundance throughout the tissue. The common approach used to address this problem 
in MALDI-MS imaging tends to be to ignore the different adduct forms and to produce 
images of signals measured from the adduct that provides the highest response.
This approach may be acceptable where sample salt content is relatively homogeneous 
throughout the tissue. In detecting compounds from tissue presenting widespread 
variation in salt content however, this approach may provide a distorted representation 
of true analyte abundance. With large scale variation in tissue salt content, variability in 
adduct formation can be quite prominent. This effect is often observed to a greater 
extent in samples such as brain tissue, plant tissue and whole body sections which 
contain two or more fundamentally similar but not identical tissue types.
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As the salt content changes from one tissue type to another, the observed ratio between 
adduct signals may change extensively. It is possible in imaging such samples that what 
might appear in the final ion image as a marked increase/decrease in analyte abundance, 
may on closer examination actually be a change in the ratio between adduct form 
signals. Whilst this issue is widely acknowledged, there are currently no reports of a 
suitable solution. The use of sample washing steps to remove tissue salts prior to matrix 
application has been introduced to facilitate effective matrix crystalisation. This method 
provides a general reduction in salt content, but may not improve the overall 
homogeneity of salt distribution. A method of post-acquisition data pre-processing that 
solves issues arising from adduct variation would be useful in MALDI-MS imaging 
research.
5 .1 .4  Matrix Coverage and Crystalisation
Further sample related issues associated with production of false images are attributed 
to the homogeneity of matrix coverage and variance in effective matrix crystalisation. 
As the MALDI process fundamentally dictates, ionisation occurs largely through energy 
interactions with matrix crystals. It is unsurprising therefore, that in regions where the 
abundance of matrix crystals is reduced, a general decrease in the ion intensity of 
spectra is observed. Clearly, when determining relative analyte abundance, a change in 
the overall ion intensity scale also results in reduced signal for analytes in those areas. 
In images it would appear that less analyte is present in these compromised regions of 
the sample.
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Variation in the ion intensity scale may arise as a result of poor matrix application, 
where matrix is unevenly distributed across the sample surface; or through ineffective 
matrix crystalisation, in regions where the salt content of the tissue is high.
Since the advent of MALDI-MS imaging, much research has been devoted to matrix 
application. Various deposition devices and automated spotting systems have been 
developed to regulate the matrix application process. The ‘ImagePrep’ station (Bruker 
Daltonik GmbH, Bremen, Germany) uses vibrational vapourisation to gently deposit 
small matrix droplets onto the tissue surface under controlled conditions.2
The Portrait 630 reagent multi-spotter provided by Labcyte (California, USA) allows 
matrix application via acoustic droplet ejection. This device can deposit volumes of 
170 pL onto the sample surface. Shimadzu Biotech (Kyoto, Japan) has developed the 
CHIP1000 chemical printer that can deposit 100 pL volume droplets of solutions onto a 
sample surface using piezo-electric technology.4
These systems have resolved the issue of normalising the volume of matrix applied over 
the tissue and also aid in preventing extensive analyte spreading. The systems fail 
however, to address the problem of variance in matrix crystalisation which is associated 
with high abundance of salts in the tissue. As a result the main attribute of these 
systems is in retention of the distribution of analytes as opposed to resolving ion 
intensity scale variation.
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Further work has been published in the hope of assessing the crystalisation issue, here a 
technique involving a two-stage matrix application is described, where samples are 
‘seeded’ with a small amount of matrix by airspray deposition before automated matrix 
spotting is carried out. It is reported that this method of application provides 
homogeneous matrix spots across the sample surface. These seeded matrix spots are 
said to be abundant in minute matrix crystals which improve peak intensity and signal 
to noise ratio.5
Sample washing may be found to reduce salt content of tissues considerably, however 
this does not resolve the adduct variation issue completely. Moreover, in some cases 
washing may result in the removal of analytes as well as salts.6 Also, with residual salts 
left in the tissue after washing, adduct process variation remains a problem.
5.1.5 M ALDI-M S Image Normalisation
Initial publications regarding pre-processing of MALDI-MS acquired image data have 
concentrated on reducing spectrum to spectrum intensity scale changes alone. This 
work has formerly been related to the analysis of high mass analytes, where variation in 
adduct processes are often less important. For the purpose of small molecule analysis 
however, it is important that adduct process variation is taken into account as well.
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The simplest means of over-riding matrix abundance issues is to normalise image 
spectra against a recorded ion intensity value. This may be carried out exclusively 
against an ion signal at a specific mass to charge ratio, or alternatively against the total 
or average ion count for the entire spectrum.7
Currently, there is widespread disagreement as to which normalisation approach is the 
most appropriate. Arguments against normalising spectra intensities to a single peak 
signal relate to concerns that ion intensity changes associated with ion suppression are 
not taken into account. Just as an area of low matrix abundance may reduce an 
observed ion signal irrespective of the compound’s abundance, normalising against an 
ion which is subject to a varying degree of suppression could lead to a similar effect. 
For this reason many researchers choose to normalise against total ion count.
The experiments described in this chapter aim to assess the benefits and disadvantages 
of single ion count (SIC) versus total ion count (TIC) normalisation. Statistical 
evaluation has been carried out to assess each method in the hope of providing some 
resolution to the uncertainty over normalisation procedures.
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5.2 Materials and Methods
5.2.1 Materials
Sample spectra were acquired from two different image datasets, the first being a H460 
human tumour xenographt. The tumour analysed was excised from a mouse previously 
treated with AQ4N. It was flash frozen immediately upon excision and stored at -80°C 
until required.
Tumour cryosections were produced at 12 pm thickness at an operating temperature of - 
20 °C. Sections were placed directly onto disposable aluminium sheets and coated in a- 
CHCA matrix (25 mg/mL in ethanol, 1.0% TFA) by air-spray depostition.
The second set of sample data was obtained from an indirect tissue image of 
hydrocortisone treated porcine skin tissue. The skin was treated over a defined 6mm 
circular area with a generic hydrocortisone formulation (0.1% w/w active ingredient) 
and incubated for 1 hour at 37°C. An imprint of the skin was made on a cellulose 
membrane using the solvent assisted blotting approach. An ethanol soaked membrane 
was air dried for 60 seconds. The membrane was then applied to the surface of the 
treated skin tissue under defined pressure for 90 seconds. The resulting tissue blot was 
coated in approximately 5 mL of a-CHCA in ethanol, 0.1% TFA in preparation for 
analysis.
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Images were acquired at 200 |jm increments using a laser power of 3.2 pJ with a laser 
ablation time of approximately 3 seconds at each position. A beta test version of the 
Applied Biosystems/MDS Sciex ‘Dynamic Pixel’ imaging mode was used during 
acquisition of the AQ4N tumour data to move the laser within the user-defined voxel 
dimensions at each point. This is employed in address to the sensitivity issue associated 
with using a Gaussian beam profile Nd:YaG laser.8
Sample spectra were taken from both sets of image data using Analyst QS 1.1 software 
(Applied Biosystems/MDS Sciex, Ontario, Canada).
AQ4N tumour data was obtained by selecting 10 sequential pixel spectra spanning 
across the width of the tissue slice. The 10 spectra were saved as text files and imported 
into the Markerview statistical analysis package (Applied Biosystems/MDS Sciex, 
Ontario, Canada) using import settings of 0.1 amu mass tolerance, 0.1 minimum ion 
intensity response and a maximum total of 2000 peaks.
The hydrocortisone blot data was obtained by randomly selecting 6 spectra from across 
the image sample. The 6 spectra were saved as text files and imported into the 
Markerview statistical analysis package using import settings of 0.1 amu mass tolerance, 
0.1 minimum ion intensity response and a maximum total of 2000 peaks.
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The purpose of using Markerview was two-fold. With the Markerview data import 
features it is possible to align spectra according to mass to charge ratio in a table format 
and to remove background noise (i.e. m/z values with an ion signal response <0.1) from 
the data. The maximum total number of peaks was set to 2000 to fit within the confines 
of data capacity and processing power of Microsoft Excel. The data table was exported 
from Markerview in text file format and further normalisation and statistical analysis 
was carried out using Microsoft Excel.
5 .2 .2  M ethods
5 .2 .2 .1 Single Ion Count N orm alisation
Single ion count (SIC) normalisation was carried out using the ion counts for the 
protonated form of the a-CHCA matrix molecule (m/z 190). A group average spectrum 
was created by working out the average ion count for each m/z value across all sample 
spectra. The ratio between the average ion count at m/z 190 and individual spectra ion 
counts for m/z 190 was then calculated by dividing the average spectrum m/z 190 value 
by the individual sample spectra m/z 190 value. The ratio determined in relation to each 
spectrum was used as multiplying factor for all ion signal responses within its own 
spectrum.
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5.2 .2 .2  Total Ion Count N orm alisation
Total ion count (TIC) normalisation was carried out using the total ion count values for 
each spectrum. A group average spectrum was created by working out the average ion 
count for each m/z value across all sample spectra. The total ion count was calculated 
for each of the sample spectra as well as the group average spectrum. The ratios 
between the total ion count of the group average spectrum and the total ion count of the 
sample spectra were then calculated by dividing the average spectrum TIC by the 
individual sample spectra TIC. The ratio determined in relation to each spectrum was 
used as multiplying factor for all ion signal responses within its own spectrum.
5.2 .2 .3  TIC N orm alisation  fo llo w e d  by SIC  norm alisation
TIC normalisation was carried out as previously described. A  new group average 
spectrum was calculated for the TIC normalised data and the TIC normalised spectra 
were then subject to the SIC normalisation procedure formerly described.
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5 .2 .2 .4  SIC N orm alisation  fo llo w e d  by TIC norm alisation
SIC normalisation was carried out as previously described. A new group average 
spectrum was calculated for the SIC normalised data and the SIC normalised spectra 
were then subject to the TIC normalisation procedure formerly described.
5 .2 .2 .5  Ion Species Specific N orm alisation
A  further method of normalization was evaluated for the hydrocortisone data which 
functions to normalize all ion species separately against the respective ion species of the 
matrix. In this method of normalization, referred to here as ion species specific (ISS) 
normalization, the ion intensities in each spectrum were normalised to the 
corresponding matrix species.
Ion species specific normalisation was carried out after assignment of ion species (i.e., 
protonated molecule, Na+/K+ adduct) to peaks in the image spectra. The assignment of 
ion species was carried out in Microsoft Excel by manually searching through m/z 
values and comparing the masses with predicted m/z values for possible adducts. This 
is explained in more detail in figure 5.1.
Where a group of related ion species could be defined, the relevant ion species were 
assigned. The ion intensities in each spectrum were normalised to the corresponding 
matrix species, i.e., peaks presumed to be non-alkali metal containing were normalised 
to the a-CHCA [M+H]+ ion at mlz 190 and others to the [M+Na]+ ion at m/z 212 or the 
[M+K]+ ion at mlz 228 as appropriate.
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Normalisation factors were calculated specifically for each ion species within each 
spectrum. For instance, normalization factors for [M+H]+ ion species were calculated 
by taking the average ion intensity for the protonated molecule of the matrix (m/z 190) 
and dividing it by the recorded ion intensity for the protonated molecule of the matrix in 
each spectrum. Each normalisation factor obtained was then used as a multiplier for all 
protonated molecule intensities within its own spectrum.
This was repeated in the same way for the sodium adducts, using the sodium adduct of  
the matrix (m/z 212) to calculate the normalization factors and again for the potassium 
adducts using the potassium adduct of the matrix (m/z 228) to calculate the 
normalization factors.
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Figure 5.1 Determining Ion Species
The assignment of ion species was carried out by predicting m/z values of other adducts 
of the same molecule. Calculations used to predict m/z values were carried out using 
the mass differences calculated between the protonated molecule (m/z 190.09), sodium 
adduct (m/z 212.08) and potassium adduct (m/z 228.06) of a-CHCA in this spectrum.
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5 2 .2 .6  S ta tistica l E valuation o f  N orm alisation  P rocedures  
Assessing Linearity o f Normalised Data
One o f the main objectives in normalising image data is to correct spectrum to spectrum 
ion intensity scale variation associated with matrix coverage and matrix crystalisation 
issues. The success of normalisation in reducing ion intensity scale variation has been 
assessed in this experiment by investigating the linear relationship between each sample 
spectrum and the group average spectrum.
A scatter plot of group average spectrum ion intensities (x) versus the sample spectrum 
ion intensities (y) was created for each sample spectrum. In displaying the ion 
intensities in a Cartesian plane in this way, a linear function equation (y=mx+c) can be 
applied in determining the overall gradient of the trend of points plotted between sample 
and group average spectra. In terms of applying this equation to the assessment of 
normalisation in this case, gradients approaching a value of 1 would show a low level of 
spectrum ion intensity scale variation comparable to the group average spectrum.
In calculating the gradient (m) in these calculations, the intercept (c) was uniformly set 
to a value of zero to ensure that the gradient of the line was unaffected by inequality in 
the scale of the axis for the two sets of spectrum intensities.
The gradient value was obtained for all samples prior to normalisation and after each of 
the different types of normalisation. The average gradient was then determined for each 
specific type of normalisation and the standard error of the mean calculated for each 
data set of gradient values.
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Assessing Correlation o f Spectra after Normalisation
Determination of the gradient of points in a Cartesian plane can be used to indicate the 
overall linear trend of x,y values. It does not, however, provide indication as to the 
strength of the linear relationship between each sample and the group average spectrum 
(i.e. how closely the points on the scatter plot fall to the line). In terms of fully 
assessing the linear relationship between spectra the Pearson product-moment 
correlation (r) has been employed. The formula o f r is shown in equation 5.1.
SZxZyr = -------- —n — 1
Equation 5.1 The Pearson Product-moment Correlation Coefficient.
The Pearson product-moment correlation coefficient is defined as the sum of the 
products of the standard scores of the two measures divided by the degrees of freedom. 
The Z score is determined through subtraction of the population mean from an 
individual score followed by division of the difference by a measure of the spread o f the 
values. In this equation standard deviation is used as a measure of the spread of values.
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The Pearson product-moment correlation coefficient can be used as a measure of the 
correlation between two variables (x and y). It indicates the tendency of the variables to 
increase or decrease together. The coefficient may range from a value of -1.0 to 1.0, 
with a score of 1.0 indicating a perfect and positive linear relationship.
A score of zero indicates that variables are completely unrelated and a score of -1.0 
indicates a perfect negative linear relationship. 9 The r2 value can also be determined to 
provide the fraction of variability in y that can be explained by the variability in x by 
their linear relationship. This equation has not been applied to this data as it results in a 
loss in the negative aspect of the Pearson formula.
A perfect positive linear relationship would imply that all points of the scatter plot fall 
on a straight line. This would rarely be the case when comparing multivariate data such 
as spectra. However, the more points that tend to fall along a straight line the stronger 
the linear relationship would be.
In this experiment the Pearson product-moment correlation has been used to determine 
the strength of the linear relationship between each sample spectrum and the group 
average spectrum. This has been applied to untreated data as well as to data after each 
different type of normalisation. The average PMCC value was then determined for each 
specific type of normalisation and the standard error of the mean calculated for each 
data set of PMCC values.
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Assessing Variation in Adduct Processes after Normalisation
The effect of different types of normalisation have been assessed as to whether each 
may carry benefits toward the issue of resolving variation in adduct processes in image 
data.
In assessing the relationship between adduct form intensities the coefficient of 
determination r has been employed. Clearly, if in theory adduct form ratios ought to 
remain stable in the absence o f salt interference, a global fit between the adduct form 
ion intensities pattern across spectra should be observed (i.e. an increase in the 
protonated form should be reflected by an increase in both the sodium and potassium 
adduct forms).
The r2 equation builds on Pearson’s correlation coefficient and therefore is also 
determinate of the correlation of the variance of y  with changes in x  and the linear 
relationship between x  and y. The r2 equation is used in interpretation o f the Pearson’s 
correlation coefficient to define the fraction of variability in y that can be explained by
0 9changes in x and their linear relationship. The scale of the r coefficient ranges from 
zero to 1.0, where a coefficient of 0.90 indicates that approximately 90% of variance in 
the y  variable can be explained by, but is not dependant upon, the x  variable. As such, 
this equation is conventionally used to provide a measure of the association between x 
and y. The formula for r2 is shown in equation 5.2.
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Equation 5.2 The Coefficient of Determination r2
For each value (x) from within the dataset, the equation calculates estimated values for y 
in relation to the specific related values of x, thus the total variability of y from the 
predicted values can be calculated and divided by the sum variability of y about its 
mean.
The phosphatidylcholine head group has been used as a model compound to assess 
variation in adduct processes before and after each method of normalisation. 
Phospholipids are abundant in many biological tissues and as such form ideal 
candidates for assessing the normalisation of adduct processes in the tumour image data. 
For each of the data sets (untreated and normalised), r2 values were calculated using the 
ion intensities across all 10 spectra for the sodium adduct of the phosphatidylcholine 
head group (y) at m/z 206 and the ion intensities for the protonated molecule (x) at m/z 
184. This was repeated in the same way using the ion intensities for the potassium 
adduct of the phophotidylcholine head group (y) at m/z 222.
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5.3 Results
5.3.1 Normalisation o f  A Q 4N  Tumour Image Data
5.3.1.1 A ssessing L inearity o f  N orm alised  D ata
In assessing the intensity scale variation between AQ4N tumour image spectra, the 
gradients of the straight line plots generated from x,y scatterplots of ion intensity 
measurements for single spectra plotted against the group average spectrum have been 
calculated. Representative data from a single selected spectrum before and after each 
different method of normalisation is shown in figure 5.2. From these data it would 
appear that SIC normalisation provides the greatest level of success in normalising ion 
intensity scale variation between spectra as both SIC and TIC-SIC normalisation o f this 
spectrum provides the gradient value closest to 1.0 (i.e. 1.04). However, on examination 
of the average gradients and standard deviation of full data sets, it is found that this may 
not be the case.
Figure 5.3 shows a graphical representation of the average gradients of the 10 spectra, 
both before and after each type of normalisation. In these results it can be seen that 
although the average gradient does not change, the reproducibility (defined by the 
standard deviation) within data sets does alter significantly. The level of reproducibility 
appears to relate directly to the final normalisation step employed.
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The gradient values for SIC and TIC-SIC normalisation are found to have a standard 
deviation of 0.45, whereas TIC and SIC-TIC normalisation have a standard deviation of 
0.15. The raw data carries a standard deviation of 0.16, therefore only normalisation 
procedures concluding in TIC normalisation appear to reduce ion intensity scale 
variation between spectra. It should be noted here that this observed improvement is 
quite small and the overall benefit of TIC normalisation remains inconclusive in the 
absence o f further evaluation of the data. Furthermore, it appears from these results that 
the inclusion of SIC normalisation alters the overall scale of ion intensities from 
between zero and -1400  to between zero and -2000. This implication of this effect is 
further evaluated in later sections of this chapter.
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Figure 5.2 Representative x,y Scatter plots for the Assessment of the Linearity 
of Normalised AQ4N Tumour Data
Plots are shown of the ion intensity values of the group average spectrum versus the ion 
intensity values for a single sample spectrum before and after each type of 
normalisation. SIC normalisation appears to have the greatest influence in increasing 
the degree of linearity between spectra.
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Figure 5.3 Average Gradients of AQ4N Tumour Spectra before and after 
Normalisation
The average gradient values determined for the sets of spectra before and after 
normalisation are shown with error bars displayed as the standard deviation (SD) for 
each data set. All data sets provide an average gradient of 1.0, however, the degree of 
error within each dataset varies (Raw SD = 0.16; SIC SD = 0.45; TIC SD = 0.15; SIC- 
TIC SD = 0.15; TIC-SIC SD = 0.45).
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5.3.1.2 Assessing Correlation o f Spectra after Normalisation
In determining the most appropriate form of normalisation the Pearson’s product- 
moment correlation coefficient has been used to assess the effects of normalisation on 
the correlation of spectra. It is important that in normalising data, the relationship 
between spectral patterns is not significantly altered. Reduction in the correlation of 
spectral patterns would indicate distortion of spectra during the normalisation process, a 
possibility which may prove to complicate image interpretation further still.
The results of the PMCC evaluation are shown in figure 5.4. From the values obtained 
it can be seen that the PMCC for each type of normalisation is comparable to that of the 
raw data and that the degree of error (defined as the standard deviation) within groups 
remains small. This would indicate that negligible change in the correlation of spectra 
is induced through normalisation. This is further evaluated in assessing the effect of 
normalisation on variation of adduct processes.
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Pearson Product-Moment Correlation Coeffeicient Evaluation
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Figure 5.4 Pearson Product-Moment Correlation Coefficient Evaulation of 
AQ4N Tumour Data
The average PMCC values are displayed with error bars shown as the standard 
deviation for each dataset. The PMCC values determined for each of the datasets as 
well as the degrees of error are highly comparable with the results given for raw data. 
This would indicate that for each type of normalisation, negligible change to the 
correlation of spectra is induced.
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5.3.1.3 Assessing Adduct Relationships after Normalisation
Variation in adduct ion relative intensities has been assessed using ions arising from the 
phosphatidylcholine head group as a model ([M+H]+ at m/z 184, [M+Na]+ at m/z 206 
and [M+K]+ at m/z 222). Figure 5.5 shows the r2 values obtained for both the sodium 
and potassium adduct intensities across the 10 spectra in relation to the observed 
intensities for the protonated molecule.
High correlation is found with raw data as would be expected in the absence of severe 
salt variations. In normalising the data it would be hoped that this level o f correlation 
would be maintained. It has been found, however that with both TIC and SIC-TIC 
normalisation a drastic reduction in the correlation between adduct ion intensities with 
the protonated molecule intensities is induced. Whilst it appears in this figure that the 
correlation is maintained in SIC and TIC-SIC normalisation, further assessment of the 
effects of normalisation may generate cause for concern. Figure 5.6 further assesses the 
effect of normalisation on the pattern of observed intensities.
In Figure 5.6 it can be seen in raw data that whilst the ion intensities o f the various 
adduct forms of phosphatidylcholine correlate with one another, they also correlate with 
the average ion count and the ion intensities of the protonated molecule o f the matrix. 
This indicates the degree of dependence of the total ion count (represented here as an 
average) on the presence of matrix. It also shows a correlation between ion intensity 
variation for phosphatidylcholine throughout the spectra in accordance with the amount 
of matrix present. This is a prime example to illustrate the necessity for normalisation.
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Normalisation should in theory reduce the correlation between analyte signals and total 
ion and/or matrix ion counts. In this sense, observed ion intensity changes associated 
with analyte signals may be attributed to actual analyte abundance as opposed to the 
presence of matrix crystals and the efficiency of ionisation.
After SIC normalisation, phosphatidylcholine signals remain relative to the average ion 
count, yet their relationship to the matrix signal is reduced. The correlation between 
phosphatidylcholine adduct forms remains strong (with r2 values of >0.6), but variation 
in average ion intensity (i.e. ion intensity scale) measurements has increased (from 
between -500-1200 in raw data to between -300-1900 in SIC normalised data).
After TIC normalisation there is a loss in the relationship between phosphatidylcholine 
signals and the average ion count, as well as the matrix response. This is coupled by a 
loss in correlation between the ion intensities for the various phosphatidylcholine adduct 
forms across the spectra.
The results of two stage normalisations appear to be largely defined by the final stage of 
normalisation. SIC-TIC normalisation provides a similar scenario to that found with 
TIC normalisation, but the average ion count is increased from -7 0 0  to -1100. TIC- 
SIC normalisation generates similar results to those found with SIC normalisation, but 
the average ion count variation is reduced from -300-1900 to -300-1700.
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Figure 5.5 Assessing the Relationship Between Adduct Processes in AQ4N  
Tumour Data
The r2 value for both the sodium adduct [M+Na]+ and potassium adduct [M+K]+ ion 
intensity patterns of the phosphatidylcholine head group in relation to the observed ion 
intensity pattern of the protonated molecule are shown. Both SIC and TIC-SIC 
normalisation show comparable levels of correlation of variance with the intensities 
recorded for the protonated molecule. The low r2 values for TIC and SIC-TIC 
normalisation indicate that there is little correlation between the intensities recorded for 
the various adduct forms after these types of normalisation.
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Figure 5.6 Assessing Ion Intensity Patterns for Phosphatidylcholine Adducts in 
AQ4N Tumour Data
The ion intensities across all 10 sample spectra are shown before and after each type of 
normalisation for phosphatidylcholine [M+H]+, [M+Na]+ and [M+K]+, a-CHCA 
[M+H]+ as well as the average ion count. It is shown that TIC normalisation 
significantly alters the general pattern of ion intensities and the relationships between 
[M+H]+, [M+Na]+ and [M+K]+ ion intensity patterns specifically.
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5.3 .2  Norm alisation o f  Hydrocortisone Treated Skin Image Data 
5.3.2.1 A ssessing L inearity o f  N orm alised  D ata
To assess the intensity scale variation between hydrocortisone treated skin image 
spectra, the gradients of the straight line plots generated from x,y scatterplots of ion 
intensity measurements for single spectra plotted against the group average spectrum 
have been calculated. A representation of the results for a single selected spectrum 
before and after each different method of normalisation is shown in figure 5.7. From 
these data it appears that ISS normalisation provides the greatest level of success with 
regards to normalising ion intensity scale variation between spectra. Closer 
examination of the full data sets further supports this.
Figure 5.8 shows a graphical representation of the average gradients of the 6 spectra, 
both before and after each type of normalisation. The results obtained for SIC and TIC 
normalised data are similar to those presented from the normalisation of the AQ4N  
tumour data in section 5.3.1.1 of this chapter. In the figures presented here it can be 
seen that although the average gradient does not change, the degree of error within data 
sets (defined as the standard deviation) does alter in accordance with the normalisation 
procedure employed.
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As with the AQ4N tumour data, SIC normalisation is found to increase the degree of 
error from a standard deviation of 0.035 in raw data to 0.299 in SIC normalised data. 
Similarly again to the AQ4N data, TIC normalisation is shown to slightly decrease the 
degree o f error to a standard deviation of 0.018. ISS normalisation, however, is found 
to reduce the degree of error further to a standard deviation of 0.006.
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Figure 5.7 Representative x,y Scatter plots for the Determination of Linearity 
of Hydrocortisone Treated Skin Data
Plots are shown of the ion intensity values of the group average spectrum versus the ion 
intensity values for a single sample spectrum before and after each type of 
normalisation. ISS normalisation shows the greatest increase in linearity between 
spectra.
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Figure 5.8 Average Gradients of Hydrocortisone Treated Skin Spectra before 
and after Normalisation
The average gradient values determined for the sets of spectra before and after 
normalisation are shown with error bars displayed as the standard deviation (SD) for 
each data set. All data sets provide an average gradient of 1.0, however, the degree of 
error within each dataset varies (Raw SD = 0.035; SIC SD = 0.299; TIC SD = 0.019; 
ISS SD = 0.006).
162
Chapter 5
5.3.2.2 Assessing Correlation o f Spectra after Normalisation
In assessing the effects of normalisation on the correlation o f spectra, the Pearson 
product-moment correlation coefficient has been applied to untreated and normalised 
hydrocortisone data. Again this equation has been used as opposed to r2 to prevent loss 
of the negative aspect of the equation.
The results of the PMCC evaluation are shown in figure 5.9. After SIC and TIC 
normalisation it can be seen that the correlation of spectra remains comparable to that of 
the raw data. ISS normalisation is found to enhance the degree o f spectral correlation 
from a PMCC value of 0.982 (in raw data) to 0.999 in the ISS normalised data. 
Furthermore, it is shown that although the PMCC for each type of normalisation is not 
found to be reduced in comparison to that of the raw data, the degree of error within 
groups (defined as the standard deviation) alters in accordance with the type of 
normalisation employed.
As with the AQ4N tumour data, the reproducibility within groups does not alter 
significantly between raw, SIC and TIC normalised data, with standard deviations of 
15.3xl0'3, 8 .8xl0 '3 and 14.1xl0'3 being recorded respectively. With ISS normalisation, 
however, there is a noted decrease in the standard deviation to a value of 0.7x1 O'3. This 
would indicate that ISS normalisation provides more than a 10 fold increase in the 
reproducibility of ion intensity scale in correlation of spectra when compared to either 
of the other normalisation techniques.
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Figure 5.9 Pearson Product-Moment Correlation Coefficient Evaluation of 
Hydrocortisone Treated Skin Data
The average PMCC values are displayed with error bars shown as the standard 
deviation for each dataset. The PMCC values determined for SIC and TIC 
normalisation as well as the degrees of error are highly comparable to the results given 
for raw data. The PMCC value for ISS normalisation is visibly higher than that of the 
raw data and either of the other normalised datasets and the degree of error is also 
significantly lower.
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5.3.2 .3 Assessing Adduct Relationships after Normalisation
For the sake of consistency, the distortion of adduct ion relative intensities in 
hydrocortisone treated skin data has been assessed in the same way as with the AQ4N 
treated tumour data in section 5.3.1.3 of this chapter, using the phosphatidylcholine 
head group associated ions as a model. Figure 5.10 shows the r2 values obtained for 
both the sodium and potassium adduct intensities across the 6 spectra in relation to the 
observed intensities for the protonated molecule.
High correlation between adduct forms is found with raw data as would be expected in 
the absence of severe salt variations. As with the AQ4N data, TIC normalisation results 
in a loss in correlation between the adduct forms. However, in contrast to the AQ4N  
data normalisation, the SIC normalisation applied in this experiment is found to enhance 
correlation between the adduct forms.
The results obtained for ISS normalisation are of particular interest, not only is the 
correlation between adduct forms shown to be increased overall, but from the r2 values 
obtained it now appears that the sodium and potassium adduct form intensities are 
equally related to the protonated molecule intensities.
This is illustrated further in figure 5.11. It can be seen that with ISS normalisation, both 
the sodium and adduct forms display matched intensities. Furthermore, whilst SIC and 
TIC normalisations produce constant intensities throughout the spectra for either the 
protonated molecule of the matrix or the average ion count respectively, ISS 
normalisation manages to combine constant intensities for both.
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Figure 5.10 Assessing the Relationship Between Adduct Processes in 
Hydrocortisone Treated Skin Data
The r  value for both the sodium adduct [M+Na]+ and potassium adduct [M+K]+ ion 
intensity patterns of the phosphatidylcholine head group in relation to the observed ion 
intensity pattern of the protonated molecule are shown. Both SIC and ISS 
normalisation show increased levels of correlation of variance with the intensities 
recorded for the protonated molecule. ISS normalisation shows complete correlation of 
[M+Na]+ and [M+KJ+ ion intensity patterns throughout spectra. The low r~ value for 
TIC normalisation indicates that there is little correlation between the intensities 
recorded for the various adduct forms after this type of normalisation.
166
Chapter 5
 P hosphati dy! chol ine |M+H ]+
Phosphatidylcholine |M+Na]+
 P hosphati dyl chol ine M+K ]+
- - “ CHCA[M+H]+
Average Ion Count
SIC  N o rm a lis e d  D a ta
200
80
20
00
80
60
40
20
0
2 3 5 6
200
180
160
140
100
80
60
40
20
1 5 62 3
Sam ple  N um ber
TIC N o rm a lis e d  D a ta IS S  N o rm a lis e d  D a ta
200
80
60
20
00
80
60
20
0 2 3 5 6
60
40
20
00
80
60
40
20
0 2 5
Figure 5.11 Assessing Ion Intensity Patterns for Phosphatidylcholine Adducts in 
Hydrocortisone Treated Skin Data
The ion intensities across all 10 sample spectra are shown before and after each type of 
normalisation for phosphatidylcholine [M+HJ+, [M+Na]+ and [M+KJ+, a-CHCA 
[M+H]+ as well as the average ion count. ISS normalisation is shown to reduce 
variation in spectral patterns associated with matrix coverage and total ion counts.
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5.4 Conclusion
In the data presented in this chapter, it has been shown that ISS normalisation holds 
great potential as a method of increasing the reproducibility o f ion intensity scale 
between image spectra. Furthermore, in assessing distortion o f alkali metal adduct ion 
relative intensities, ISS normalisation is found to be more suitable than the other types 
of normalisation evaluated.
Whilst neither SIC nor TIC normalisation (either used singularly or in combination) 
appear to deteriorate the degree of correlation between sample spectra and the relative 
group average spectrum, it is found that with SIC normalisation the reproducibility of 
ion scale intensity between spectra is considerably reduced. In contrast, where SIC 
normalisation appears to reduce the distortion of alkali metal adduct ion relative 
intensities, TIC normalisation appears to increase the distortion effect.
In conclusion, from the data presented here, it may be assumed that ISS normalisation is 
the most appropriate method for reducing spectrum to spectrum ion intensity scale 
changes and distortion of adduct ion relative intensities simultaneously. In terms of 
MALDI-MS image analysis, this would dictate that normalisation of ion images against 
the respective matrix ion species is a valid means of data manipulation to be adopted in 
the reduction of both ion intensity scale variation and alkali adduct ion relative intensity 
distortion.
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Chapter 6
6 Multivariate Analysis in MALDI-MS Imaging
6.1 Introduction
Manual interpretation of scientific data can be extremely laborious and time-consuming. 
With datasets containing large numbers of discrete variables the task becomes more 
challenging still. In a study carried out on several thousand samples where each of 
those samples contains thousands of distinct variables, it is unrealistic to imagine that 
any useful information might be gained by attempting to correlate such data by hand.
A MALDI-MS image file may contain upward of 1000 sample spectra and (depending 
on the mass range of the experiment) each sample spectrum may contain literally 
thousands of ion signals. The recorded intensity for each of these signals may vary 
from one spectrum to the next, either dependently or independently from other ion 
signals within the spectra. In a blind study it would be unfeasible to assume that any 
correlation of ion signal variance could be determined by simply sifting through the 
image spectra manually. Less likely still is the possibility of defining a specific ion as 
accounting for a tangible degree of variance between discrete groups of sample spectra 
from within the image.
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The data produced in MALDI-MS imaging may contain vast amounts of valuable 
information. Aside from the target analytes of the experiment, there may be any 
number of other hidden variables that could also prove pivotal to the research. 
Currently, most MALDI-MS imaging experiments are directed toward determining 
distributions of known analytes. The remaining data that are acquired is often 
disregarded.
In terms of fully utilising the wealth of information provided by MALDI-MS image 
analysis, a method is required which will allow the user to determine ions of interest 
from within these large multidimensional datasets. As these ions of interest are likely to 
be associated with variance in spectral patterns, statistical approaches may be adopted to 
mathematically sort through the data.
Some statistical approaches have already been tested in their application for assisting 
MALDI-MS image data evaluation. These primarily include principal components 
analysis (PCA) and hierarchical cluster analysis (CLA) methods. To date methods have 
been used to classify image pixels by spectral similarity, largely for the purpose of 
enhancing image quality and for defining spectral patterns associated with various tissue 
types.1
In this form of statistical approach, it is the spectral patterns rather than specific ions 
that are proven to be associated with defined image pixels. By no means may any o f the 
ions assigned in a spectral pattern be regarded as being definitive of a particular tissue 
type.
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As yet there are few reports of these statistical approaches being applied in a more 
refined manner, for example, for the direct determination of latent variables as tissue 
specific ions or ions which are present at elevated abundance in a certain tissue type. A  
method which could singularly pinpoint ions accounting for variance within an image 
would reduce the workload for analysts considerably.
Principal components analysis has been applied for the evaluation of MS data in a range 
of different studies. It has been used in the classification of edible oils based on their 
triacylglycerol composition determined by fast atom bombardment FAB-MS2 as well as 
for the investigation of gasoline adulteration by gas chromatography GC-MS.3 In more 
detailed biological studies developed to determine biomarkers using liquid 
chromatography (LC) MS, PC A has been shown to be a useful tool for discriminating 
between serum samples of variable protein concentration.4
In this chapter the use of PCA is investigated for its ability to define ions of interest 
from within MALDI-MS image datasets. Whereas previously this statistical approach 
has been applied to MALDI-MS image data solely for data reduction purposes (as a 
preliminary step toward further statistical evaluation), it is intended here that its use 
alone may provide the ability to pinpoint ions that may be confined to (or present 
elevated abundance in) defined regions within an image.
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PCA is conventionally used as a means of reducing multidimensional data into lower 
dimensions of space, as such it is a useful technique for finding patterns in data of high 
dimensionality.5 The end result is that highly complex data can be presented in a format 
that is more amenable to examination by the analyst. With the correct experimental 
ethos and view towards interpretation, PCA may provide greater insight as to which 
ions may be specific to certain tissue types or defined tissue regions within an image.
PCA is achieved through orthogonal linear transformation, where computation of the 
eigenvalue decomposition of a dataset allows transformation of the data onto a new 
coordinate system in relation to variance. Rather than having to assess ion intensity 
variability by comparing spectrum to spectrum differences one by one, the variables are 
themselves sorted into those presenting the greatest amount of influence in spectral 
variance between samples. The samples as well as the variables are aligned into 
graphical representations which can be interpreted to show which variables relate best to 
which samples.
The first coordinate (or the first principal component) is determinate o f the greatest 
variance by any projection of the data. With mass spectrometry data this relates to ions 
accounting for the greatest variance between all spectra. The second coordinate (the 
second principal component) would be determinate of the second greatest variance, and 
so on, until negligible variance can be applied.
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Each variable (in this case an m/z value and its associated ion intensity) is given a 
loading in respect to its own influence in each principal component assignment. These 
loadings are presented on the relevant principal component axis. Variables may then be 
displayed in a Cartesian plane between two principal component axis, where the x and y  
values for any given variable are provided by the computed loading of that variable with 
respect to each principal component axis selected.
In order to relate this information back to the original samples, a second plot o f the 
scores for each sample (in this case each spectrum) can be displayed. The score values 
assigned to each sample indicate the weighting that a selected principal component 
carries within that sample. For example, samples presenting a positive PCI score are 
likely to carry high ion intensity signals for ions with positive PCI loading; samples 
presenting a negative PCI score are, by comparison, likely to carry low ion intensity 
signals for ions with positive PCI loadings. Again these sample scores can be presented 
in a Cartesian plane between two principal component score axis.
6.1.1 Determining Principal Components to Separate Sam ple Groups
A clearly defined separation of sample groups in the PCA scores plot is useful for 
determining hidden variables. This may be achieved by manually searching through the 
different principal components to determine which variables best distinguish one group 
of samples from another.
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Figure 6.1 illustrates the PCA results found for two sets of sample spectra. In this 
experiment 10 spectra were taken from an image of a Viagra tablet and a further 10 
spectra were taken from a similar placebo tablet. It would be expected on the basis of 
sample scores with respect to one or more principal components that these spectra could 
be separated into the relevant tablet image groups.
As can be seen from the scores plot in figure 6.1 (a) the sample groups are clearly 
defined by their PCI score. Sample spectra taken from the Viagra tablet image present 
positive PCI scores. In contrast, sample spectra taken from the placebo tablet show 
negative PCI scores.
On closer examination of the loadings plot in figure 6.1 (b) it would appear that the ion 
at m/z 475.3 accounts for a large proportion of the variance between the samples. This 
ion presents a positive PCI loading which would indicate that this variable may be 
found at elevated levels in the Viagra tablet samples and represents the protonated 
molecule of sildenafil(l-[4-ethoxy-3-(6,7-dihydro-l-methyl-7-oxo-3-propyl-1/7-
pyrazolo[4,3-J]pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine citrate)) which is the 
active component of the Viagra tablet. Graphical representation o f the ion intensities 
recorded for this ion across both groups of sample data (figure 6.1 c) shows that this is 
indeed the case.
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This simple representation illustrates the benefits of PCA in defining specific ions of 
interest. Whilst in this experiment the two groups of spectra are shown to be separated 
completely, with the high levels of mass spectral complexity found in biological tissue 
data, this is rarely the case. A more likely scenario would be a complex scores plot, in 
which the sample groups are less clearly defined. Moreover as the number of sample 
groups investigated rises or where the tissue types are highly biologically related, the 
level of overlap between group scores may increase significantly.
The principal components indicate the ions associated with the largest degree of 
variance between all samples rather than those accounting for the largest variance 
between defined sample groups. As such, there is currently some ambiguity 
surrounding which principal components to concentrate on in determining ions of 
interest in this application. Clearly, if  the wrong principal components are selected, this 
produces problems in determining ions which may be specific to or elevated in a certain 
image region or tissue type. Part of this chapter is aimed at investigating a novel 
approach of interpreting PCA scores plots such that predictions can be made with 
regards to which principal components are likely to best separate the sample groups.
177
Chapter 6
(a) (b)
Scores for PC1 (68.7 Z) versus PC2 (18.4 Z). Pareto. Use Groups
30 40 50
Loadings for PC1 (68.7 Z) versus PC2 (18.4 Z). Pareto. Use Groups 17Z07
- 190.09146.C10 f 4
441-10 173.084
  • - 443.10335.16 401.15-#  •" •A*164.11 V 1147.
304.364 497.2808 4??30 4686.35 j .  4310.28-#  f  "  ''•  473.28“ !9 1 ! ^  -  >478.29103.15439.11
- . 463,08-
489.29 404.21 306.36--
PC1 Loading
475.304
(C)
□  Viagra Tablet Spectra S  Placebo Tablet Spectra
1200
1000
800
>.
inca> 600c
co
400
200
1 2 3 4 5 6 7 8 9 10
Sample Number
Figure 6.1 PCA of Viagra and Placebo Tablet Data
The PCA scores plot (a) shows clear separation of the sample groups. Viagra tablet 
(green) spectra uniformly present highly positive PCI scores and placebo tablet (red) 
spectra uniformly present highly negative PCI scores. This would indicate that in the 
loadings plot (b), ions showing highly positive PCI loadings would be found at elevated 
levels in the Viagra tablet (green) spectra.
The graph (c) representing the ion intensities for the m/z 475.30 ion across both Viagra 
and placebo tablet spectra clearly shows that this ion is highly elevated in Viagra tablet 
spectra in comparison to placebo tablet spectra.
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6.1.2 Data Pre-processing for Statistical Image Data Evaluation
As well as the innate complexity of biological systems data, the MALDI-MS imaging 
process is found to generate unwanted complexities of its own. These relate to the 
induced experimental errors addressed in chapter 5 of this thesis.
The introduction of experimental error may not only prove to invalidate images, but can 
also in some circumstances have negative effects on statistical evaluation of the data as 
well. This effect is less prevalent in cases where spectral patterns vary significantly, for 
example in defining differences between highly distinctive tissue types. In the 
determination of small scale changes in spectral pattern however, PCA may prove 
inadequate in resolving sample groups in the presence of other more extreme variants 
(such as variability introduced during the experimental process).
A particular instance in which this problem may become relevant is in the analysis of a 
drug treated tissue. Whilst a relatively uniform tissue would predict that the spectral 
pattern may remain relatively constant throughout the sample, the presence of a 
pharmaceutical compound ought to change the spectral pattern sufficiently that drug 
treated regions can be easily defined using PCA. Clearly, in consideration of the low  
concentrations of pharmaceutical compound that may be present, the change in spectral 
pattern would be quite small. With the addition of experimentally induced sample 
variability (such as variation in matrix coverage) it is possible that this small change in 
the spectral pattern might not be apparent in PCA results.
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This problem may seem of little importance in evaluating drug distribution study data, 
with PCA not being required when the analyst has prior knowledge o f the compound 
being analysed. The issue, in this instance, does not relate to defining sample groups 
for the purpose of distinguishing a single unknown variant as described before, but 
rather to finding the separation of groups based on a known variant such that ions of 
correlated variance can be determined. This approach may find application in 
determining a correlated distribution of other compounds in the tissue. These 
compounds may be drug metabolites, or perhaps more importantly, may be related to 
changes in the tissue instigated by the presence of the administered compound (i.e 
pharmaco-dynamic markers)
The second part of this chapter is aimed at assessing the benefits of post-acquisition 
data pre-processing (as investigated in chapter 5 of this thesis) for the purpose of 
revealing more information in the PCA.
6.2 Materials and Methods 
6.2.1 Materials
The use of PCA in distinguishing ions of interest from MALDI-MS image data has been 
assessed using data derived from a rat brain sagittal tissue section MALDI-MS image 
data set. This sample was chosen due to the diverse yet fundamentally similar nature of 
this tissue type.
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Brain tissue exhibits distinction between grey and white matter. The grey matter, 
consisting primarily of neuron cell bodies; glial cells; capillaries; and short nerve cell 
processes, is responsible for processing, relaying and re-routing of sensory and motor 
stimulus in order to create response. White matter consists of myelinated nerve cell 
processes and is responsible for communication between the grey matter regions. Due 
to the high level of communication between white and grey matter, these different tissue 
types are locally inter-related and many regions of the brain contain both white and grey 
matter in some form. In these experiments the aim is to determine differences in lipid 
distributions throughout the brain tissue.
Assessment of the effects of data pre-processing for PCA was carried out on data 
derived from an indirect MALDI-MS image of hydrocortisone treated porcine skin. 
This sample was chosen due to the relative homogeneity of the tissue to assess whether 
PCA would be capable of defining drug treated regions of the tissue from untreated 
regions of the tissue.
The methodology used in preparing the sample for MALDI-MS analysis as well as the 
method used in extracting the data for PCA is explained below.
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6.2.1.1 Sample Preparation of the Sagittal Rat Brain Section
The rat brain sagittal tissue section MALDI-MS image data was provided by a 
colleague, Paul Trim, of the Sheffield Hallam University Biomedical Research Centre.
To prepare the sample for MALDI-MS image analysis the brain tissue was removed 
from the rat using standard procedures. The tissue was snap-frozen in liquid nitrogen 
cooled isopentane immediately after excision and was then stored at -80°C prior to 
sectioning.
Sagittal sectioning of the brain tissue was performed using a Leica CM 1550 cryostat 
(Leica Microsystems, Wetzlar, Germany). Sections were produced at 12 pm 
thicknesses in the absence of embedding medium under a cryostat operating 
temperature of -18°C. The sections were thaw mounted onto disposable aluminium 
plates in preparation for ethanol washing and matrix application.
Washing of tissue sections was carried out in order to reduce tissue salt content by 
immersion of the sample plate in several gradients of ethanol. The samples were 
subject to 30 second washes in 50:50, 70:30 and 90:10 ethanokwater solutions, 
followed by a final immersion in pure ethanol solvent.
All images were run at 100 pm resolution with a laser power of 30% using a beta test 
version of the Applied Biosystems/MDS Sciex ‘Dynamic Pixel’ imaging mode as 
described in chapter 2 of this thesis.
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6.2.1.2 Sample Preparation of the Drug Treated Porcine Skin
The hydrocortisone treated porcine skin image data was derived from a sample 
presented in chapter 3 of this thesis. The sample preparation methodology and data 
acquisition parameters are defined in chapter 3 o f this thesis.
6 .2 .2  M ethods
Sample spectra were obtained directly from image data to evaluate the potential of PCA 
in determining ions of interest from within MALDI-MS image data sets. A method of 
determining the principal components that best define sample groups was evaluated and 
the results of the PCA were assessed against their correlation with the relevant ion 
images.
6.2.2.1 Extracting Sam ple Spectra fo r  PCA
In selecting sample spectra for PCA, the o-MALDI server imaging software was used to 
define pixel co-ordinates from with the image file.
A total of 10 pixel spectra were selected at random from each o f 6 defined tissue regions 
of the brain sagittal section image. The brain regions examined were the cerebral cortex; 
the hippocampal formation; the grey cerebellar cortex; the corpus capsulum; the 
thalamus; the ophthalmic bulb and the white cerebellar cortex.
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From the hydrocortisone treated porcine skin image data a total of 10 pixel spectra were 
selected randomly from within the drug treated region of the tissue. A further 10 pixel 
spectra were randomly selected from within the untreated region of the tissue.
Analyst QS software was then used to select the defined pixel spectra from the image- 
file data. The pixel spectra were saved as text files for further use in PCA.
6 .2 .2 2  P rincipal Com ponents A nalysis
All PCA was carried out using a beta test version of the Markerview™ statistical 
analysis package (Applied Biosystems/MDS Sciex, Ontario, Canada). Text spectra 
were imported using a mass tolerance of 0.1 amu and a minimum response of 4.0 ion 
counts. A mass window of 500-1000 amu was used to reduce interference of matrix on 
the results of the PCA. PCA was carried out using pareto scaling and the principal 
component scores and loadings calculated for the data were exported into Microsoft 
Excel for further analysis.
6.2 .2 .3  Separation o f  Sam ple G roups B ased  on PCA Scores
The key to determining variants that might be specifically related to a group of samples 
is to ensure the best separation of groups in the PCA scores plot. In determining the 
ideal principal component values to plot to allow the best separation of sample groups 
in a scores plot, the PCA scores for each principal component have been investigated.
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The use of conventional statistical methods in determining grouping o f sample scores is 
hindered by the fact that these approaches require that within each sample group a 
normal distribution of values should be observed. Preliminary investigation of the PCA 
scores of sample groups showed that a normal distribution was rarely present within the 
data. As a result experiments have been carried out to assess a new method of 
determining principal components that provide the best separation of sample groups.
In these experiments the separation of the sample groups has been assessed by looking 
at the difference in average score for each group versus the standard deviation of the 
scores within each group. This has been done for all the sample group scores with 
respect to each separate principal component. The principal components providing the 
greatest difference in mean score between groups as well as the lowest level of 
deviation from the mean score within a single group ought to define the principal 
components which most clearly define the sample groups.
For the best separation of sample groups to occur, the distance between the group mean 
scores ought to exceed the standard deviation of the scores within each group. Clearly 
if the standard deviation of scores within a group was to be greater than the distance 
between group mean scores, overlap of sample groups in the scores plot would be 
observed. It is unlikely however, in the context of these experiments that complete 
separation of groups would occur. As these samples are heavily related in many aspects, 
a certain degree of overlap will most likely be found.
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To minimize the degree of overlap between sample groups, principal components 
chosen to display the data should be those which provide the most positive response in 
relation to the spread of group mean scores versus the deviation of scores within the 
group.
For each group of samples the mean PCA score was calculated. The standard deviation 
of scores within each sample group was also calculated. The average standard deviation 
of all the group scores was calculated and this was then subtracted from the standard 
deviation of the group mean scores. This was repeated for the group PCA scores for 
each principal component.
6.2 .2 .4  D eterm ining L aten t Variables in M ALDI-M S Im age D ata
The information gathered in evaluation of the separation of sample groups based on 
PCA score was used as a means of selecting principal components to define ions that 
best distinguish between the groups of sample spectra. The ions which were found to 
account for the largest degree of variation between the two sample groups were selected 
and used in creating ion images to demonstrate the potential of PCA in selecting ions of 
interest from MALDI-MS image data.
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62 .2 .5  Assessment o f Data Pre-processing fo r  PCA
In comparing the effects of normalisation on the results of PCA, the image data from 
the hydrocortisone treated porcine skin tissue was used. PCA results are compared for 
the raw data versus data normalised using the ion species specific normalisation 
procedure illustrated in chapter 5 of this thesis.
In this experiment the aim was to determine first of all whether PCA was capable of 
grouping spectra taken from treated and untreated regions of the tissue and secondly 
whether it was capable of defining the hydrocortisone related ions as accounting for the 
variance between sample groups.
Several sample spectra were taken from the hydrocortisone treatment area of the image 
and several sample spectra were taken from the untreated tissue regions of the image. 
PCA was carried out before and after ISS normalisation and the results were compared.
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6.3 Results
6.3.1 Determining Ions o f  Interest by PCA
PCA has been evaluated in its ability to determine ions of interest within data taken 
from a MALDI-MS image of a rat brain sagittal section.
The separation o f sample groups based on evaluation of PCA scores was carried out. In 
this experiment the sample groups were defined by grey or white matter regions of the 
brain. The results are shown as a graphical representation in figure 6.2. From this 
evaluation it would appear that PCI is the only viable principal component capable of 
clearly defining the two sample groups. Looking at the distribution of the sample scores 
for each group with respect to each principal component (figure 6.3), it would appear 
that the calculations used do indicate the separation of groups quite clearly. Based on 
these data it is thought that this method of assessing the separation of groups of data on 
PC scores may be useful in determining the optimum principal components to plot.
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Figure 6.2 Principal Components Separating Sample Groups
From the results shown it would appear that PC 1 provides the most positive response in 
separating the groups of sample spectra taken from the grey and white matter regions of 
the brain tissue section image.
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Figure 6.3 Assessing Separation of Groups by PC Score Range
The range of the PC scores within each group of sample spectra are shown for PC 1 to 
PC8. The range of PC scores for the grey matter sample spectra are shown in red and 
the range of PC scores for the white matter sample spectra are shown in blue. From 
these data it can be seen that PCI scores provide the greatest degree of separation of 
these two groups of data, as predicted by the results of the calculations presented in 
figure 6.2.
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6.3.2 Determining Latent Variables in MALDI-MS image data by PCA
The PCA scores and loadings plots from this analysis are shown in figure 6.4. From the 
scores plot it is clear to see the distinction between grey and white matter regions of the 
brain in relation to the PCI score. Sample spectra taken from the grey matter regions of 
the brain have a predominantly negative PCI score and sample spectra taken from the 
white matter regions of the brain have a predominantly positive PCI score. Using this 
information to interpret the loadings plot shown in figure 6.5, it may be assumed that 
ions presenting a negative PCI loading will present elevated abundance in the grey 
matter regions o f the brain. In contrast, ions present a positive PCI score ought to be 
elevated in white matter regions of the brain. The two ions which appear to be 
accounting for the highest level of variance between the grey and white matter spectra 
are m/z 734.57 (predicted to be elevated in grey matter) and m/z 788.62 (predicted to be 
elevated in white matter).
The ion images presented in figure 6.6 represent the distribution of the two ions (m/z 
734.57 and m/z 788.62) which appear to be accounting for the greatest degree of 
variance in ion signal between the grey and white matter regions of the brain. From 
these images it is clear that the PCA has been successful in defining ions which 
correlate with elevated signals in the respective regions of the brain.
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Figure 6.4 Principal Components Scores Plot for the Brain Image Data
The principal components scores plot shows clear separation of the sample spectra taken 
from the grey and white matter regions of the rat brain image on the PCI axis. Grey 
matter sample spectra present predominantly positive PCI loading whist white matter 
sample spectra present a predominantly negative PC 1 loading.
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Figure 6.5 Principal Components Loadings Plot for the Brain Image Data
The principal Components loadings plot indicates the influence of each ion in the 
principal components. As the separation of the sample spectra was found to be related 
to PCI score, PCI loadings of the ions are used for defining ions of interest. The grey 
matter sample spectra presented predominantly positive PCI in the scores plot, 
therefore it may be assumed that ions presenting a positive PCI loading would be 
elevated in the grey matter regions of the brain. As white matter sample spectra 
presented a predominantly negative PCI loading, it may be assumed that ions 
presenting a positive PCI loading would be elevated in the white matter regions of the 
brain. Ions which appear to be accounting for the largest degree of variance between 
the grey and white matter sample spectra are indicated.
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Figure 6.6 Distribution of Ions of interest in the Rat Brain Sagittal Section
Schematic diagrams of the brain show the areas from which sample spectra were 
selected. These are separated in to the grey and white matter regions defined by the 
PCA. The images of the distribution of the ions accounting for the largest degree of 
variance between grey and white mater regions are displayed. The ions are found to 
present elevated in the corresponding regions of grey and white matter.
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6.3.3 Assessment of Hydrocortisone Treated Skin MALDI-MS image
In the following experiment the ion which may be thought to account for the largest 
degree of variance by PCA was hydrocortisone, the protonated molecule of which exists 
at m/z 363.2. PCA was carried out on the raw and ion species specific (ISS) normalised 
data to determine what effect this normalisation procedure had on the results of the PCA, 
both in terms of sample grouping in the scores plot and in defining hydrocortisone as a 
variant between the sample groups.
6.3.3.1 Evaluating Separation  o f  Sam ple G roups by PCA
The separation of sample groups based on evaluation of PCA scores was carried out for 
both the raw and ISS normalised hydrocortisone data. The results are shown as a 
graphical representation in figure 6.7. The results obtained for the raw and ISS 
normalised data are identical. This would indicate that ISS normalisation does not 
distort MALDI-MS image data. From these evaluations it would appear that PC3 is the 
only viable principal component capable of clearly defining the two sample groups. 
Based on these data further evaluation of the effects of ISS normalisation on PCA 
results has been carried out using plots of PC3 versus PCI.
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Figure 6.7 The Effects of ISS Normalisation on Sample Grouping
Sample grouping appears to be unaffected by ISS normalisation. This may 
further validate that MALDI-MS image data is not negatively affected by this 
type of normalisation.
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6.3.3.2 Assessing the Effects o f ISS Normalisation on PCA Results
The effects of ISS normalisation on PCA results are shown in figure 6.8. As predicted 
by the calculations carried out to determine the effects of ISS normalisation on sample 
grouping, samples appear to maintain a similar group configuration in the PCA scores 
plots both before and after ISS normalisation.
The PCA loadings plots for the raw and ISS normalisation may initially appear to be 
quite different. For the raw data, all ions present a positive PCI loading. The ions are 
divided by positive and negative loading in relation to PC3. The PCA results obtained 
from the ISS normalised data produced a loadings plot where the ions appear to have 
been grouped in clusters.
197
Chapter 6
Raw Data
Scores for PC1 (52.8 % ) versus PC3 (4.4% ), Pareto
0 —
-20 10-10 0
Loadings for PC1 (52.8 %} versus PC3 (4.4 % ). Pareto 
304.34
156.07
4461 5n.i * 234.05i
250.02
204.15
228.04265.11
241.17
210.12
J 2 7  14
363.27
PC1 Score
0.2
PC1 Loading
ISS Normalised Data
S cores for PC1 (51.3 % ) versus PC3 (6.7 % ), Pareto
0 -
-10
-30 -20 -10 0 10
Loadings for PC1 (51.3 % ) versus PC3 (6.7 %), Pareto
363.27
0.2
0.1 - 
0. 0 - =  
-0.1 - 
-0.2 
-0.3 4
379.14
170.08 j 15^ 09 2 2 7 : U
•  L  •  291.14 •
A  V  • -------401.13
174.07 380.1 210.12
r 04.......•f* * V V BZ17.
2 2 f f  417.1 | f  ^ X 2 2 9 l 19 2^ 15
4J .O 8 f "  4 3 9 0 9  16| 13
2534.05 250.02 266
i  * - 1 5 6 .0 7
304.34„ A.
-0.1
PC1 Score
0.0 0.1 
PC1 Loading
0.2
Figure 6.8 The Effect of ISS Normalisation on PCA Results
The PCA scores and loadings plots are shown for PCI versus PC3, as PC3 was found to 
provide the best separation of sample groups based on PCA scores. The PCA results 
indicate that ISS normalisation has little effect on sample grouping as predicted by the 
results presented in figure 6.7. ISS normalisation does, however significantly alter the 
loading of ions with respect to each principal components. After ISS normalisation 
grouping of ions in the loadings plot may also be observed.
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63.3 .3  Extracting Useful Information form PCA
The loadings plots of the raw and normalised data have been used to determine ions 
which may be present at elevated levels in the drug treatment region of the skin image 
(i.e. in areas where hydrocortisone is most abundant). Ions whose distribution 
correlates with the distribution of hydrocortisone ought to be found in a similar position 
of the loadings plot as the molecular ion of hydrocortisone (m/z 363.2). Figure 6.9 
highlights the areas on each of the loadings plot where these ions may be found.
In assessing the PCA results from the raw and normalised data, it can be seen that the 
same ions are found to correlate with hydrocortisone distribution irrespective of whether 
normalisation is carried out or not. This would indicate that prior normalisation of data 
is not essential for successful PCA.
The only difference observed in these data is that in the PCA loading plot generated 
from the raw data m/z 228 distribution appears to correlate with hydrocortisone 
distribution. As m/z 228 is the potassium adduct of the matrix, it appears that the only 
effect that ISS normalisation prior to PCA has is the removal of matrix interference 
from the PCA results. Figure 6.10 shows the MALDI-MS images of the distribution of 
the protonated molecule of hydrocortisone at m/z 363.27 as well as the images of the 
distribution of ions m/z 152.09 and m/z 291.14. There is a remarkable similarity 
between the distribution hydrocortisone and the distribution of these ions through out 
the sample.
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Figure 6.9 Selecting Ions of Interest by PCA
Ions of interest in this experiment are those which may be related to the presence of 
hydrocortisone in the sample. Ions that are localised around the molecular ion of 
hydrocortisone (m/z 363.27) in the loadings plot are likely to have a similar distribution 
throughout the sample.
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(a) (b) (c)
Figure 6.10 Images of Ions of Interest Selected by PCA
Images of the distribution of (a) the molecular ion of hydrocortisone at m/z 363.27, (b) 
m/z 152.09 and (c) m/z 291.14 are shown as normalised against the relevant matrix ions 
species. Both ion m/z 152.09 and ion m/z 291.14 show a similar distribution to 
hydrocortisone.
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6.4 Conclusions
Principal components analysis has been shown to be a useful tool in reducing the 
amount of data to be searched when determining ions of interest from MALDI-MS 
image data. PCA was successful at defining ions which may account for differences in 
lipid distributions between the grey and white matter regions of the brain.
Evaluation of the effects of data normalisation as a data pre-treatment step before PCA 
showed that it may not necessarily be a required step in defining ions of interest in 
MALDI-MS image data. PCA was still successful in determining ions which correlated 
with the distribution of hydrocortisone in the treated skin samples, and the ions 
indicated were the same as those found when PCA was carried out on ISS normalised 
data. Although the PCA scores and loadings plots looked different for the raw versus 
ISS normalised data, the sample grouping calculations for each principal component 
turned out to be identical for raw and normalised data.
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7. Conclusions and Suggestions for Future Work
The evaluation of the high repetition rate laser produced some interesting results with 
regards to the laser beam profile. In contrast to the expected Gaussian profile, a 
speckled beam profile was observed. Nitrogen lasers are conventionally applied in 
MALDI-MS imaging experiments and also have a speckled laser profile. However, 
rather than a static speckle pattern, as is observed with the Nd:YAG laser, the nitrogen 
laser naturally modulates the light pattern such that the hot spots (i.e. high energy areas 
of the laser spot) are moved around within the laser spot.
Applied Biosystems/MDS Sciex have overcome the static speckle pattern profile 
problem by altering the imaging software such that the laser spot moves around in a 
figure of 8 within each image pixel. This method, known as 'dynamic pixel image 
mode' has significantly improved the sensitivity of the Nd:YAG laser. The only 
problem found with the dynamic pixel imaging mode is that there is a limitation on the 
resolution of images that can be acquired. As the image resolution approaches 50 pm, 
the ion signals observed become extremely low. Clearly as the pixel size becomes 
smaller than the laser spot size, laser movement is inhibited.
Bruker Daltonics (Massachusetts, USA) have an alternative solution to the sensitivity 
issues of Nd:YAG lasers. They have developed the Smartbeam™ laser which has the 
characteristics of the Nd:YAG laser (i.e. high laser energy, long laser lifetime and high 
repetition rates) combined with the performance o f the nitrogen laser.
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In this thesis a method has been developed in which the laser profile of an Nd:YAG 
laser is modulated by simply moving/vibrating the fibre optic feed. This not only 
enhances sensitivity of the NdiYAG laser, but also allows imaging at resolutions higher 
than 50pm. Further work needs to be carried out to determine the exact limitations for 
image resolution, but based on the results observed so far it is thought that resolutions 
<20pm are attainable. However, this would be highly dependant upon the abundance of 
the analyte(s) being observed.
Direct and indirect imaging methods have been evaluated for the analysis of different 
compounds and tissues. The solvent assisted indirect imaging approach was found to be 
useful in cases where analytes were difficult to analyse directly form the tissue. In this 
case it was the skin tissue that was difficult to analyse due to poor matrix crystalisation 
on the skin surface.
This indirect imaging approach may also be useful in instances where there is a high 
level of ion suppression occurring within a sample. Selectively extracting the target 
compound(s) out of the tissue containing the suppressant ought to allow for a more 
sensitive analysis.
Sample preparation has been proven to be an important factor in MALDI-MS image 
analysis, where the analysis of the active metabolite of the prodrug AQ4N (AQ4) was 
found to be dependant upon the pH of the matrix.
Both chapters 2 and 3 illustrate the importance of optimisation o f the sample 
preparation procedure and show how this should be specifically tailored toward tissue 
type as well as the properties of the target compound(s).
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The method o f ion species specific normalisation appears to hold potential as a 
resolution to the many variables observed in MALDI-MS image data. The method 
appears to be able to simultaneously resolve variation in ion signals associated with the 
distribution of salts and matrix crystals throughout tissue sections. Additionally this 
method resolved spectrum to spectrum changes in the ion intensity scale, a feature 
previously attributed solely to total ion count normalisation.
It was thought that ISS normalisation may be a useful means o f pre-treating data prior to 
statistical analysis. In chapter 6, principal components analysis of ISS normalised 
image data is compared with the PCA results observed from the raw data. In contrast to 
the expected findings (i.e. a much clearer interpretation of the hyperspectral data) it was 
found that ISS normalisation of data prior to PCA had little effects other than to remove 
matrix interference from the data.
In consideration of the assessment of ISS normalisation in chapter 5 this is possibly not 
so remarkable, as ISS normalisation out-performed both single ion count and total ion 
count modes of normalisation in each area assessed. One interpretation of this result is 
that ISS normalisation provides reduction in the variability that can distort ion images, 
but that ISS normalisation does not significantly alter the actual relationships between 
ion intensities within the image spectra.
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The results presented in this thesis draw to a number of interesting conclusions from 
which further research may be carried out. In terms of the findings of the evaluation of 
the high repetition rate laser, it is suggested that further research should be carried out 
with regards to the use of adapting the laser for use in static imaging mode by 
incorporation of a vibrating mechanism to vary the speckle pattern in the profile of the 
laser.
The method of ion species specific normalisation may be o f particular benefit to 
MALDI-MS imaging. It is suggested that further evaluation should be carried out to 
ensure that the normalisation process is not affected by different levels of ion 
suppression between the protonated molecule and sodium and potassium adducts.
Principal components analysis appears to hold potential for use as a tool for 
determination of biomarkers within tissues. It would be useful to validate this method 
with a comparison between healthy and diseased tissue (e.g. tumour and normal tissue).
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